Utah State University

DigitalCommons@USU
All Graduate Theses and Dissertations

Graduate Studies

8-2022

Intra-Operative Language Assessment for Adult Brain Tumor
Survivors: A Systematic Review
Carissa Jolley
Utah State University

Follow this and additional works at: https://digitalcommons.usu.edu/etd
Part of the Communication Sciences and Disorders Commons, and the Education Commons

Recommended Citation
Jolley, Carissa, "Intra-Operative Language Assessment for Adult Brain Tumor Survivors: A Systematic
Review" (2022). All Graduate Theses and Dissertations. 8497.
https://digitalcommons.usu.edu/etd/8497

This Thesis is brought to you for free and open access by
the Graduate Studies at DigitalCommons@USU. It has
been accepted for inclusion in All Graduate Theses and
Dissertations by an authorized administrator of
DigitalCommons@USU. For more information, please
contact digitalcommons@usu.edu.

INTRA-OPERATIVE LANGUAGE ASSESSMENT FOR ADULT BRAIN
TUMOR PATIENTS: A SYSTEMATIC REVIEW
by
Carissa Jolley
A thesis submitted in partial fulfillment
of the requirements for the degree
of
MASTER OF SCIENCE
in
Communicative Disorders and Deaf Education
(Communication Sciences)
_________________________________
Lisa Milman, Ph.D., CCC-SLP
Committee Chair

_________________________________
Joann Tschanz, Ph.D.
Committee Member

_________________________________
Ronald Gillam, Ph.D.
Committee Member

_________________________________
Randy Jensen, M.D., Ph.D.
Committee Member

____________________________________
D. Richard Cutler, Ph.D.
Vice Provost of Graduate Studies
UTAH STATE UNIVERSITY
Logan, Utah
2022

ii

Copyright © Carissa Johnston 2022
All Rights Reserved

iii
ABSTRACT

Intra-operative Language Assessment for Adult Brain Tumor Patients:
A Systematic Review
by
Carissa Johnston, Master of Science
Utah State University, 2022
Major Professor: Dr. Lisa Milman
Department: Communicative Disorders and Deaf Education
Awake craniotomy and language assessment procedures for brain tumor survivors
can drastically affect patient outcomes and quality of life. The goal of intra-operative
language mapping is to help preserve vital communicative functions. However, there is
currently no standardized set of measures for intra-operative language assessment. This
systematic review identified behavioral language measures used during intra-operative
procedures and the resulting outcomes for adult brain tumor patients, with the aim of
helping clinicians and researchers select intra-operative language assessments supported
by the highest levels of evidence.
PRISMA guidelines were used to systematically identify articles. Patient
demographic and medical information, neuroimaging data, intra-operative language
assessment measures, language outcomes, and quality of evidence data was obtained
using a data extraction manual and form. Descriptive methods were used for synthesis of
the information.
The nineteen identified articles included a total of 471 patients with a variety of
tumor types and tumor severity. Direct electrical stimulation (DES) was used across all
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studies, with a few utilizing supplemental neuroimaging methods. Across studies, 37
language measures were used peri-operatively to assess 21 different language domains,
and 26 language measures were used intra-operatively to assess 18 different language
domains. The majority of patients (88%) reported as working prior to resection were able
to return to work. Eight studies were classified as American Academy of Neurology
(AAN) evidence level 3, ten studies as evidence level 2, and one study as evidence level
1. Discussion: This review supports awake language mapping during tumor resection and
identifies the most widely used measures and associated language outcomes during postoperative stages. Further research is needed to establish best practice for selecting intraoperative assessments best suited for individual patient needs.
(103 pages)
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Intraoperative Language Assessment for Adult Brain
Tumor Patients: A Systematic Review
Introduction
More than 308,000 new cases of central nervous system (CNS) primary tumor are
diagnosed each year (Central Brain Tumor Registry of the United States, CBTRUS,
Ostrom et al., 2019; Globocan, 2020). Although brain tumor (BT) patients are frequently
combined with stroke/traumatic brain injury patients in discussions of recovery
trajectory, BT patients present differently than other patient populations with respect to
language and other behavioral characteristics (Anderson et al., 1990; Davie et al., 2008).
Surgical resection of the tumor, the most common initial medical treatment (McFalineFigueroa & Lee, 2018; Meng et al., 2015; Ritaccio et al., 2018), can further impact
cognitive-communicative functions, and subsequently the survivor’s quality of life. It is
also widely recognized that various surgical procedures, including intra-operative
cognitive assessment, can differentially affect outcomes in a variety of patient
populations and tumor types (Dziedzic & Bernstein, 2014; Duffau 2018; Kanno &
Mikuni, 2015; McGirt et al., 2009; Saito et al., 2015). Currently, however, there is no
standard of care for intra-operative language assessment of brain tumor survivors
undergoing tumor resection.
Surgical procedures for brain tumors include biopsy, craniotomy, endoscopy, and
laser ablation (John Hopkins Medicine, 2021). Awake craniotomy is considered by many
to be the gold standard for resection of supratentorial tumors, particularly for lesions in
motor or language areas (Dilmen et al., 2016; Duffau, 2018; Leal et al., 2017; Raffa et al.,
2019; Ritaccio et al., 2018). A critical issue in awake craniotomy is optimizing oncofunctional balance (i.e., maximizing the extent of tumor resection while preserving vital
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functions). Gross total resection is associated with longer survival rates (Brown et al.,
2016; Chang et al., 2011; Chikenzie et al., 2017; Duffau, 2018; Ritaccio et al., 2018;
Sanai & Berger, 2010; Xia et al., 2018) but can be associated with greater morbidity
affecting functions such as language and related cognitive domains that affect quality of
life (De Witt Hamer et al., 2012; Duffau, 2013; McGirt et al., 2009).
A variety of neuroimaging methods to maximize tumor resection without
compromising vital functions have been developed (Tarapore et al., 2012). Recent
imaging methods of interest include intra-operative fluorescent imaging to augment
visual separation of cancerous margins from healthy tissue (Lakomkin & Hadjipanayis,
2018; Nagaya et al., 2017); and intra-operative MRI (iMRI) to monitor intra-operative
brain shift (Gandhe & Bhave, 2018; Caras et al., 2020). Awake procedures such as direct
electrical/electrocortical stimulation (DES) allow neurosurgeons to define boundaries of
functional neural tissue and thereby make decisions about what tissue can be excised.
Historically, DES is the standard for intra-operative mapping of cerebral tumors in
eloquent areas. Though some debate exists about the relative effectiveness of awake
craniotomy and intra-operative DES relative to other surgical procedures (Buchfelder &
Zhao, 2018; Nossek et al., 2013; Rutten et al., 2002), it has remained the most widely
used and researched approach to achieving onco-functional balance. Evidence shows that
the procedure results in higher extent of resection, longer survival time, and better postoperative neurological outcomes than when surgery is done under general anesthesia (Bu
et al., 2020; De Witt Hamer et al., 2012; Dziedzic & Bernstein, 2014; Groshev et al.,
2017; Sacko et al., 2011). Studies have found that this technique is the most sensitive in
identifying essential language areas (De Witte et al., 2013; Mandonnet et al., 2010),
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allows mapping of subcortical tissue (Duffau, 2018; Mandonnet et al., 2010), and
provides direct, immediate feedback (Duffau, 2015).
During the DES procedure, electrodes are used to stimulate specific sites in the
brain with an electric current. During the electric pulse, which usually lasts 2-8 seconds
(Ritaccio et al., 2018; Saito et al., 2015; Szelényi et al., 2010), the patient is asked to
complete various assessment tasks. Disruption of vital functions such as speech,
language, or motor activity during DES indicates that the stimulated tissue is part of an
essential circuit associated with that function and that removal is likely to have negative
effects on patient outcomes. Since language is vulnerable to both tumor pathology and
neurosurgery, it is almost always assessed as part of the DES procedure (Duffau, 2018;
Sanai et al., 2008). Selection and/or administration of the language assessment tasks is
primarily the responsibility of a speech-language pathologist (O’Neill et al., 2020;
Sefcikova et al., 2019) or neuropsychologist (Kelm et al., 2017; Sanai et al., 2008;
Sefcikova et al., 2019).
Due to the nature of awake craniotomy, intra-operative imaging, and DES, it is
essential that all assessment tasks are completed within a relatively short time interval. A
patient may be awake from 45 minutes to a couple hours, depending on the size and
location of the tumor (Raeke, 2018). Tasks used to intra-operatively evaluate language
vary widely due to differences associated with tumor histology and presentation (Ostrom
et al., 2019), procedural differences across clinicians and/or institutions (Mandonnet et
al., 2017; Sefcikova et al., 2020) and/or when batteries are tailored to individual patient
language profiles based on preoperative assessments (Chan et al., 2019; Hall et al. 2021).
Many studies report using brief screening tests (Satoer et al, 2016). The most basic
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battery includes simple movement and speech/language tasks such as systematic
counting, reading, and naming (Ottenhausen et al., 2015; Sanai et al., 2008; Zanin et al.,
2018). Other tasks used to assess language might include spontaneous speech, semantic
associations, and repetitions. Occasionally tasks probing additional cognitive functions,
such as memory or simple calculations, are also included (O’Neill et al., 2020;
Ottenhausen et al., 2015; Rofes, Mandonnet, et al., 2017; Ruis, 2018; Talacchi et al.,
2012).
The importance of intra-operative language mapping cannot be overstated; by
assessing language functions intra-operatively, surgeons can determine which specific
microregions of the cortex are still functioning in language processing and thus preserve
critical areas necessary for post-surgical performance. Ultimately, the goal is to
maximally preserve abilities that support post-surgical language use and participation
across a range of social and vocational contexts. Given the importance of awake
craniotomy to patient outcomes and quality of life, it is imperative that the intraoperative
language assessments used during these procedures are adequate for determining “vital”
tissue (Mandonnet et al., 2020; Miceli et al., 2012).
In 2013, De Witte et al. evaluated common standardized intraoperative language
tasks and the scientific theory behind them. They concluded that most intraoperative
tasks (such as those described above) were not standardized and had limited
psychometric data; sensitivity of various language tasks needed further research; and that
most literature lacked valid scientific basis. Since then, a number of individual protocols
specifically for intraoperative language assessment have been developed, such as the
Dutch Linguistic Intra-operative Protocol battery (DuLIP, Alves et al., 2020; De Witte et
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al., 2015); the Russian Naming Test for mapping noun and verb production of Russian
speakers (Dragoy et al., 2016; Dragoy et al., 2020); the verb and noun test for perioperative testing with DES or nTMS mapping (VAN-POP, Ohlerth et al., 2020); and
strategies for simultaneous assessment of speech and motor function (Mandonnet et al.,
2017). However, the available literature supporting these protocols consists mainly of
descriptive clinical reports and single cases studies. Furthermore, many studies focus
primarily on medical aspects, such as extent of resection or anesthesia protocols, rather
than language assessment and post-operative language outcomes.
Other related reviews have focused on pre-operative and post-operative (vs. intraoperative) neuropsychological assessment of brain tumor patients (Noll et al., 2019), a
broad survey of intra-operative assessment tasks employed across diverse clinical groups
(Ruis, 2018), and a critical review focusing specifically on intra-operative assessment of
syntax, also for a mixed clinical group (Zanin et al., 2017). The general consensus from
these reviews (which collectively evaluated literature up to 2016) was that there was a
need to balance the special requirements of intra-operative language assessment with the
need for higher psychometric standards. Specific recommendations included: 1)
Increased use of standardized core language protocols, 2) more comprehensive
assessment of language (and other cognitive domains), and 3) longitudinal post-surgical
language outcome assessment to validate the selection of specific intra-operative
language measures.
This systematic review follows up on these recommendations and evaluates the
evidence supporting language assessment of adult brain tumor patients during awake
craniotomy. Following up on previous recommendations is invaluable in understanding
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current state-of-the-art procedures and in planning future research. Additionally,
evaluation of evidence supporting current protocols has the potential to guide future
decisions made by clinicians for selecting intra-operative language assessments supported
by the most current and highest levels of evidence, thereby directly and positively
impacting brain tumor survivor quality of life.
Specific research questions included: 1) What are the demographic and medical
characteristics of the brain tumor patients included in these publications? 2) What
neurosurgical procedures are associated with awake language mapping? 3) What
language assessment tasks/measures are associated with awake mapping? 4) What
language outcomes are reported following awake mapping? and 5) What is the quality of
evidence for this literature?

Methods
Inclusion/Exclusion Criteria
Since the goal of this paper was to identify and evaluate cutting-edge procedures
currently being used in practice, inclusion criteria were crafted to ensure that only studies
with the highest levels of evidence would be included. Studies selected for inclusion met
all of the following criteria: 1) available in English; 2) published in a peer-reviewed
journal and contained original research; 3) published between 1976-June 2021 (electronic
search 2014-2021); 4) was an experimental or quasi-experimental study, or correlational
study comparing relation between pre-/intra- and post-operative treatment variables; 5)
included at least one adult patient or participant (over 18 years of age) with a diagnosis of
brain tumor; 6) identified the intra-operative neuroimaging technique(s) used; 7) included
intra-operative assessment of at least 3 language domains; 8) at least one of the three
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intra-operative language domains was assessed using a standardized and/or experimental
task that is replicable (i.e., a published measure and/or adequate description of
administration, cueing, stimuli, scoring, and interpretation procedures allowing for
replication); 9) reported post-operative language outcome data using at least one
standardized language assessment. For the full form used to screen articles, see Appendix
A.
Search Strategies
Search strategies included an electronic search, an ancestral search, and a citation
search. PRISMA guidelines (Schlosser, Ralph, & Sigafoos, 2007; Shamsheer et al., 2015)
were followed for each of the strategies.
Studies were identified by: 1) searching for relevant papers in previous related
reviews covering the time period between 1976-2016 (DeWitte & Marien, 2013; MartinMonzon et al., 2020; Rofes & Miceli, 2014; Ruis, 2018; Zanin et al., 2017); 2) an
electronic search covering 2015-to June 2021; and 3) ancestral and descendent searches
of all identified articles.
Electronic Search Databases and Terms. The electronic search was completed
using the PubMed, Web of Science, and PsychInfo databases. Each database search was
completed separately, with key terms being coded according to the specifications of each
individual database. The search terms below were entered into PubMed as given; the
same terms as they were coded for the other databases (as recommended by USU and U
of U librarians) can be found in Appendices B (PsychInfo) and C (Web of Science). In
order to maximize consistency across the three databases, no limiting terms or filters
were used other than publication year.
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Search terms as entered into PubMed:
language OR speech OR apraxia OR aphasia OR communication [Mesh] OR "auditory
comprehension" OR listening OR reading OR writing OR conversation OR discourse OR
naming OR "word retrieval" OR "sentence production" OR "sentence comprehension"
OR grammar OR linguistics OR semantics OR spelling OR linguistic OR "action
naming" OR "verbs and sentences" OR “spontaneous speech” OR "language
disorders"[Mesh] OR eloquent OR dyslexia OR “reading comprehension” OR alexia
AND resection OR "awake craniotomy" OR "awake surgery" OR neuronavigation OR
"intra-operative imaging" OR neurosurgery OR craniotomy OR "direct electrocortical
stimulation" OR " intra-operative magnetic resonance imaging" OR "direct electrical
stimulation" OR "intra-operative stimulation mapping" OR "cortical stimulation" OR
"intra-operative monitoring" OR "diagnostic imaging" [Mesh] OR "aphasia/surgery"
[Mesh] OR "intra-operative neurophysiological monitoring" [Mesh]) AND (glioma OR
tumor OR cancer OR astrocytoma OR ependymoma OR glial OR glioblastoma OR
malignant OR meningioma OR medulloblastoma OR metastasis OR oligodendroglioma
OR oncology OR chondrosarcoma OR craniopharyngioma OR cyst OR hemangioma OR
hemangioblastoma OR hemangiopericytoma OR lipoma OR lymphoma OR
neurofibromatosis OR oligoastrocytoma OR schwannoma AND evaluation OR
assessment OR test OR task OR "standardized test battery" OR analysis OR tool OR
protocol OR screening OR measure OR "mapping diagnostic" OR monitoring OR
examine OR investigate OR probe OR questionnaire OR standardized OR "non
standardized" OR appraising OR "neuropsychological tests" [Mesh] OR "language tests"
[Mesh] OR “mental status test” AND brain OR cerebral OR cortical OR subcortical OR
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frontal lobe OR parietal lobe OR temporal lobe OR occipital OR limbic OR thalamic OR
cranial OR “central nervous system” OR “arcuate fasciculus” OR “longitudinal
fasciculus” OR “posterior cingulate cortex” OR “uncinate fasciculus” OR “frontooccipital fasciculus” OR “parietopontine” OR “cingulate cortex”.
The electronic search yielded a total of 1, 898 original articles for screening (see
Figure 1). A total of 15 articles from this search method met the inclusion criteria.

Ancestral and Descendant Search
Both the ancestral and descendant searches were completed for all articles
included in the review (See Figure 1).
An ancestral search was completed by screening all references within the articles
that met inclusion criteria. For the descendant search, all included articles were entered
into Google Scholar and citations checked for additional relevant articles. Relevant
articles were screened to see if they met the inclusion criteria. An additional four articles
were identified through these methods, with ancestral and descendant searches also being
completed for each new addition.
Study Selection
Initial screening of all articles, regardless of the search strategy by which they
were identified, consisted of reviewing article titles and abstracts for relevance. If it was
unclear from the title and abstract if the article should be included/excluded, each
reviewer independently accessed the entire article to determine inclusion/exclusion. To
ensure reliability, a second screener independently reviewed 50% of the records. All
reviewers used a standardized form developed specifically for this study (Appendix A) to
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increase intra-coder agreement. Inclusion reliability was 98.3%, and any disagreements
were discussed until a consensus was reached.
The search process identified a total of 19 papers for inclusion. See Figure 1
below. For the list of references for all included articles, see Appendix D.
Figure 1
Study Inclusion Flowchart

Data Extraction
An adapted (from Milman et al., 2017; Watt, 2018) data extraction manual
(Appendix E) and spreadsheet were used to extract information from the included
articles. The form focused on five primary areas: 1) participant information such as basic
demographics (e.g., age, gender, language(s) spoken) and medical status (e.g., tumor
laterality, type, severity), 2) neuroimaging data related to intra-operative language
mapping (e.g., candidacy restrictions, type(s) of imaging employed, extent of resection),
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3) pre-, post-, and intra-operative language assessment data (e.g., tasks, language
domains assessed, standardization); 4) post-operative language outcomes (e.g., timing of
follow-ups, language impairments) and 5) key indicators of research quality (e.g., design,
blinding, intent to treat) of included studies using quality indicator scales (e.g., ASHA QI,
RoBiNT, PEDro).
A second coder independently extracted information from 57.9% (11/19) of the
included articles. All coding was conducted by SLP graduate students who successfully
completed reliability coding training (measured by 80% reliability accuracy on at least
one training paper previously coded by both CJ and LM with 100% agreement). Interrater
reliability was derived by dividing the total number of items that the coders agreed on by
the total number of items coded. Interrater reliability was calculated as 95%. All
disagreement was discussed until there was complete consensus.
Data Synthesis and Interpretation
A reference list of included articles was generated (see Appendix D). Tables and
figures display data regarding study inclusion, patient demographics and medical
characteristics, intra-operative imaging, language assessment, outcomes, and research
quality indicators. Due to variability across studies (protocols and tasks, demographic
characteristics, tumor location, study design), descriptive/qualitative synthesis was used,
following procedures modeled by previous reviews (Murray et al., 2018; Noll et al.,
2019; Ruis, 2018; Watt, 2018; Zanin et al., 2018).
Results
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Data regarding patient demographics and medical characteristics, intra-operative
imaging, language assessment, outcomes, and research quality are presented in the text
and tables below.
Participant Demographics
Demographic data for all participants are summarized in Table 1. Of 586
participants from the included studies, 471 (80%) were brain tumor survivors that
underwent awake craniotomy. Of the 471 brain tumor participants undergoing awake
craniotomy (plus 3 additional participants whose gender information was inseparable
from the reported brain tumor survivor (BTS) data), 278 were male and 196 were female.
The weighted average age of the brain tumor survivors was 44.7 and ranged from 15 to
75. Participants were recruited from various nations in Europe (n= 16 studies) and Asia
(n= 3 studies). Of the available data, severity of pre-existing language impairments was
classified as mild (n= 31), moderate (n=2), severe (n= 3), or unspecified (n= 91). The
study by Leote et al. (2020) excluded patients with aphasia (as determined by an error
rate greater than 50% on any of the given language tests) and Zigiotto et al. (2020) only
considered patients for awake craniotomy if the individual had “no language deficit,
confusion and/or anxiety disorder” (p. 98). Reported comorbidities included seizures (n=
45), hemiparesis (n=11), intracranial hypertension (n=8), unspecified motor deficit (n=6),
central facial palsy (n=1), astereognosia (n=1), and dysphagia (n=unspecified).
Brain Tumor Characteristics
Brain tumor characteristics are summarized in Table 2. Tumors were localized to
the left hemisphere (n= 372), right hemisphere (n=81) or were unspecified (n=18). In
most cases tumors were restricted to a single cortical lobe or region, including tumors
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restricted to the frontal lobe (n= 182), the temporal lobe (n=99), the parietal lobe (n= 40),
the occipital lobe (n=4), insula (n=20), paralimbic (n=10), and subcortical areas (n=5). In
addition, tumors were reported in diffuse areas (spanning more than one lobe) (n=80) or
were unspecified/described without quantitative data (n=31). Diffuse tumors spanned two
(n= 71) or three (n=9) lobes. Tumor subtypes were also identified as astrocytoma (n=76),
glioblastoma (n= 76), oligodendroglioma (n= 47), oligoastrocytoma (n= 11), glioma (n=
247), oligodendroglioma astrocytoma (n= 1), neuroglial (n=1), gliosarcoma (n=1),
ependymoma (n=1), cavernoma (n=4), DNET (n=2), and metastasized (n= 4). Tumors
were further classified (WHO, Louis et al., 2016) as grade I (n=2), as grade II (n= 130),
between grades II and III (n= 4), grade III (n= 47), and grade IV (n= 36); or simply
described as “low grade” (n= 88),“high grade” (n= 106), “other” (n= 7), or grade was not
reported (n= 51).
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Table 1
Participant Demographics
Study

BTS
underwent
AC /Total

Age
Mean
(Range)

Gender
(M/F)

Language(s) Spoken (n)
or country where study
conducted

Description of Baseline (pre-operative) Language
Impairments (n)

Comorbidities (n)

48
(21-72)
35
( +5.1a)
-c
(32-68)
41
(20-65)
46
(41-53)
44
(27-58)
50
(31-68)

13/10

Italy
Austria
Italy
Taiwan
Netherlands
French (10); FrenchArabic Bilingual (1)
Portuguese (19)

Speech (7), general cognition (7)

Hemiparesis (2), Dysphagia
(unspecified)
None

40
(21-72)
VM :44
(36-40),
No VM:
46
(25-62)
42
(21-52)

6/5 b

France
Spain

6/2

44
(17-69)
43 c
(16-73)
49
(37-70)
BTS: 38
(19-62)
NHC: 39
(19-62)

33/17

participants
Altieri et al.
(2019)

23/23

Bartha et al.
(2000)

5/5

Bello et al.
(2007)

88/88

Chang et al.
(2018)

17/19

De Witte et
al. (2015)

3/3

Herbet et al.
(2019)

11/11

Leote et al.
(2020)

19/19

Mandonnet
et al. (2019)

10/12

Martino et
al. (2018)

32/32

MoritzGasser et al.
(2013)
Motomura
et al. (2020)

8/8

Nakajima et
al. (2019)

66/66

Rofes et al.
(2017)

6/6

Satoer et al.
(2018)

18/39

50/50

3/2
43/45
9/10b
3/0
7/4
11/8

20/12

39/27
4/2
15/3

Mild articulation (1), Mild writing (1), Moderate fluency
(2), Severe fluency (2)
Mild impairment (23)

“Mild motor deficit” (6)

-

-

None

None

Mild naming (1)

-

General language (6); Aphasia (3)

-

Contralateral hemiparesis
(1), Central facial palsy (1),
Seizures (12)
Seizures (11)

General language (3)

-

France

Naming (2); Semantics (4); semantic fluency (6)

-

Japan
Japan
Italian (6)

-

-

-

-

General language Mild (4), Severe (1)

-

Netherlands

Mild deficits in incomplete sentences, naming, and
categorical fluency (BTS group)

-
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Study

BTS
underwent
AC /Total
study
participant
s

Age
Mean
(Range)

Gender
(M/F)

Language(s) Spoken (n)
and/or country where
study conducted

Baseline (pre-operative) Language Impairments (n)

Comorbidities (n)

Signorelli et
al. (2007)

28/101

53
(28-74)

17/11

France and Italy

Mixed aphasia (5), Nonfluent aphasia (7), Memory (5)

StarowiczFilip et al.
(2020)
Tomasino et
al. (2020)

15/15

48
(24-63)

10/5

Poland

3/9 ACE III score below 82, 5/9 ACE III below 88

Seizures (15), Intracranial
hypertension (8), Facialbrachial hemiparesis (8),
Astereognosia (1)
-

49/49

24/25

Italian (49)

7/7

5/2

Zigiotto et
al. (2020)

16/33

10/6

None d

None

Totals

471/586

51
(32-74)
(15-74)

French-English Bilingual
(1), French (4), English
(1), Not specified (1)
Italian (16)

Reading (7), verbal short-term memory (2), object naming
(8) action naming (12), verbal fluency (7)
Mild reading (1)

-

Zemmoura
et al. (2015)

42
(15-67)
42
(23-59)

278/196

Europe (16), Asia (3)

Seizures (45),
Hemiparesis (11),
Intracranial hypertension
(8), Motor (6), Central
facial palsy (1),
Astereosgnosia (1),
Dysphagia (unspecified)
NHC=Neurologically Healthy Controls; BTS= brain tumor survivors, VM= DES with verbal memory mapping; No VM= did not do verbal memory during intraoperative DES; ACE III = Addenbrooke's Cognitive Examination
a
Standard deviation; range not available
b

Sex of patient(s) that did not undergo AC remained unspecified

c

Median data only/ mean not available

d

awake criteria included no lang impairment

-

Seizures (7)
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Table 2
Tumor Characteristics
Study (n)
Altieri et al. (2019)
(n=23)

Tumor Laterality
(L/R)
13/10

Anatomic Area of Tumor

Tumor Type

Tumor Grade

Fronto-temporo-insular (3), Frontal (8),
Parietal (2) Fronto-parietal (2), Frontoinsular (1), Parieto-insular (1) Parietotemporal (6)
Involvement of Hippocampus, Amygdala,
and Basal ganglia, Insula, pre-post central
gyrus, superior temporal gyrus, temporal
pole, frontal operculum, inferior frontal
and supramarginal gyrus
Frontal (39), Paralimbic (10), Temporal
(32), Parietal (7)
Frontal lobe (12), Parietal (1), Frontotemporal (3), Fronto-parietal (1), Frontoinsular (1), Insula (1) b

DNET (1), Astrocytoma (4),
Oligodendroglioma (6), Anaplastic
astrocytoma (3), Glioblastoma (9)

I (1), II (10), III (3),
IV (9)

Astrocytoma (4), Oligodendroglioma (1)

I (1), II (3), III (1)

Glioblastoma (36), Anaplastic glioma (8),
Glioma (44)
Glioblastoma (2), Anaplastic astrocytoma
(4), Anaplastic Oligoastrocytoma (4),
Diffuse Astrocytoma (3),
Oligodendroglioma (4)

Low grade (44), High
grade (44)
II (7), III (8), IV (2)

Bartha et al. (2000)
(n=5)

5/0

Bello et al. (2007)
(n=88)
Chang et al. (2018)
(n=17)

69/1

De Witte et al. (2015)
(n=3)

3/0

Temporo-parietal (1), Fronto-temporal (1),
Parieto-occipital (1)

Astrocytoma (2), Oligoastrocytoma (1)

II/III (3)

Herbet et al. (2019)
(n=11)
Leote et al. (2020)
(n=19)

11/0

Temporal (10), Temporo-occipital (1)

Diffuse glioma (11)

II (11)

19/0

Temporal (6), Frontal (8), Parietal (2),
Insula (3)

High grade (8) a

Mandonnet et al. (2019)
(n=10)
Martino et al. (2018)
(n=32)

7/3

Insula (10)

Anaplastic astrocytoma (2), Astrocytoma
(4), Glioblastoma (5), Oligodendroglioma
astrocytoma (1), Oligodendroglioma (6),
Neuroglial (1)
IDH-mutated glioma (10)

20/12

Supplementary motor area (12), Lateral
premotor/frontal operculum (6), Superior
parietal/postcentral gyrus (1), Insula (6),
Temporal (7)

Glioma (22), Anaplastic glioma (10)

II (22) a

Moritz-Gasser et al. (2013)
(n=8)
Motomura et al. (2020)
(n=50)

8/0

- (Temporal or temporo-occipital regions)

Glioma (8)

II (8)

34/16

Superior frontal (31), Middle frontal gyrus
(10), Inferior frontal gyrus (1), Precentral
gyrus (5), Cingulate gyrus (3)

Diffuse astrocytoma (21),
Oligodendroglioma (13), Oligoastrocytoma
(4), Anaplastic astrocytoma (5), Anaplastic
oligodendroglioma (7)

II (38), III (12)

a*

17/0

-
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Study
Nakajima et al. (2019)
(n=66)
Rofes et al. (2017)
(n=6)

a
b

Tumor Laterality
(L/R)
36/30
6/0

Anatomic Area of Tumor

Tumor Type

Tumor Grade (n)

Frontal (31), Temporal (18), Parietal (14),
Occipital (3)
Prefrontal (5), Parietal (1)

Glioma (66)

II (24), III (19), IV
(23)
II (2), III (3), IV (1)

“Language areas” (Inferior frontal
gyrus/supramarginal gyrus/angular
gyrus/inferior temporal gyrus/middle
temporal gyrus/superior temporal
gyrus/"Subcentral Gyrus) (11); “Nonlanguage areas” (Precentral gyrus/middle
frontal gyrus/superior frontal gyrus) (5),
Unspecified (2)
Temporal (10), Parietal (4), Frontal (3),
Temporo-parietal (3), Fronto-parietal (1),
Paracentral lobule and supplementary
motor area (2), Temporo-insular (3),
Fronto-temporo-insular (2)

Satoer et al. (2018)
(n=18)

16/2

Signorelli et al. (2007)
(n=28)

27/1

Starowicz-Filip et al. (2020)
(n=15)

15/0

Temporal (3), Parietal (1), Frontal (8)
Temporo-insular (3)

Tomasino et al. (2020)
(n-49)

49/0

Zemmoura et al. (2015)
(n=7)
Zigiotto et al. (2020)
(n=16)
Totals (n=471)

7/0

Temporal (6), Frontal (13), Parietal (5),
Fronto-temporo-insular (4), Temporoinsular (3), Temporo-parietal (10), Frontotemporal (3), Temporo-occipital (1),
Frontal-insular (2), Frontal-medial orbital
(1), Temporo-hippocampal (1)
Hippocampus (2), Temporal (3), Occipital
(1), Left fusiform/occipital lobe (1)
Temporal (4), Frontal (8), Parietal (2),
Tempero-insular (2)
Frontal (182), Temporal (99), Parietal
(40), Occipital (4), Insula (20), Diffuse
(80), Paralimbic (10), Subcortical (5),
Unspecified (31)

10/6
372/81
Not reported= 18

Rest not reported
2 additional participants not with BT included; unable to specify

Oligodendroglioma (2), Oligoastrocytoma
(1), Glioblastoma (1), Astrocytoma (1),
Anaplastic astrocytoma (1)
Glioma (18)

Low grade (11), High
grade (7)

Mixed glioma (2), Oligodendroglioma (7),
Anaplastic oligodendroglioma (1),
Gliosarcoma (1), Metastasis of epidermoid
carcinoma (1), Pilocytic astrocytoma (2),
Recurrent ependymoma (1), Glioblastoma
(13)
Astrocytoma diffusum (11), Astrocytoma
malignum (1), Glioblastoma (1), Glioma
miatum paritum anaplasticum (1),
Oligoastrocytoma (1)
Metastases (3), Cavernoma (4), Pilocytic
astrocytoma (1), Glioma (40), DNET (1)

II (3), Low grade (5) a

Glioma (7)

II (7)

Anaplastic astrocytoma (7), Glioblastoma
(9)
Astrocytoma (76), Glioblastoma (76),
Oligodendroglioma (47),
Oligoastrocytoma (11), Glioma (247),
Oligodendroglioma astrocytoma (1),
Neuroglial (1), Gliosarcoma (1),
Metastasized (4), Ependymoma (1),
Cavernoma (4), DNET (2)

High grade (16)

II (12), II/III (1), III
(1), IV (1)

Low grade (28), High
grade (14), Other (7)

I (2), II (130), II/III
(4), III (47), IV (36),
Low grade (88),
High grade (106),
Other (7), Not
reported (51)
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Neurosurgical Procedures Associated with Awake Language Mapping
Neurosurgical procedures related to language mapping during awake craniotomy
are summarized in Table 3. Six studies provided criteria for awake craniotomy candidacy,
including characteristics such as age (n=1 study), tumor location (n= 2 studies), presence
of cardiac pacemakers (n=1 study), anesthesiologic contraindications (n=1study),
indications of intracranial pressure (n= 1 study), behavioral abilities (n=1 study),
psychological profiles (n=2 studies), and presurgical aphasia or language deficits (n= 2
studies). DES was used in all of the included studies. Imaging techniques paired with
DES included: intraoperative ultrasound (iUS) (n=1 study), navigated fMRI (nfMRI)
(n=1 study); intraoperative MRI (iMRI) (n=1 study); and monitoring of electrical
discharge through electrocorticography (eCoG) (n= 2 studies). For DES electrical
stimulation, all studies used a bipolar probe stimulator, with frequency widths 50-60 Hz.
Amperage varied, and the duration of stimulations ranged from one millisecond to four
seconds. Extent of Resection (EOR) was reported as gross total (n= 77), subtotal/partial
(n= 48), supratotal (n= 46), and four studies (Altieri et al., 2020; Martino et al., 2018;
Satoer et al. 2018; Tomasino et al., 2020), including a total of 122 participants, reported
group data with reported ranges of 12.6-202%.
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Table 3
Neurosurgical Procedures Associated with Awake Language Mapping
Study (n)

I/E Criteria of AC
Candidates

Type of
Intraoperative
Imaging (n)

Imaging Specifications

EOR

Altieri et al.
(2019)
(n=23)
Bartha et al.
(2000)
(n=5)
Bello et al. (2007)
(n=88)

- a tumor not in highfunctional area

DES (23), eCoG (23)

DES: bipolar electrode
eCoG: stimulation intensity of 2.5 mA to 10 mA

Median 82.42% (R:
12.6-100%)

-

DES (5)

-

GT (2), ST (3)

No symptoms of high
intracranial pressure or
preexisting language
impairment
-

DES (88)

Bipolar electrode (60 Hz, pulse duration 1 ms to 4 s),
amplitude began at 2 mA0.and increased by 0.5 mA

-

DES (17)

Bipolar electrode (50 Hz, pulse duration 1 ms), amplitude
ranged from 2 to 10 mA

GT (11), ST (3),
“partial” (3)

-

DES (3)

-

ST (3)

-

iUS (11); DES (11)

-

- a lesion less than 20 mm
from language brain
regions or pathways, less
than 50% on presurgical
neuropsychological tests,
no cardiac DES
pacemakers
“Behavioral traits judged
incompatible with
procedure; sub optimal
participation during awake
period expected” due to
age
-

DES (19), nfMRI
(13)

Bipolar electrode (60-Hz, pulse width 1-ms); amperage
ranged from 1 to 4 mA
DES: bipolar electrode (60 Hz, pulse duration 1000ms),
amperage ranged from 1 to 5mA
nfMRI: used to inform and modulate the effort dispended
(time and number of stimuli) for DCS at a specific brain
region.

DES (10)

(60 Hz; pulse duration 500 microseconds) amperage ranged
from 1 to 3 mA

GT (1), ST (7),
partial (4)

DES (32)

- * “bipolar electrode (60 Hz, pulse duration 1 msec),
amplitude ranged from 2 to 8 mA)

-

DES (8)

-

DES (50), iMRI (50)

-

DES (66)

Amplitude began at 1.5 mA and increased by 0.5 mA until
reproducible response obtained
DES- bipolar electrode (60 Hz; pulse duration 0.5 msec)
amperage ranged from 1 to 2mA- 8 mA
iMRI-"0.4-T vertical field MR scanner
-

VM group Mean:
82.2% (20.2-100%)
No VM group
Mean: 79% (51100%)
-

-

DES (6)

-

DES (18)

-

b

DES (28 ); eCoG
(28),

“Able to tolerate
intraoperative functional
monitoring until terminal
stage of resection”
-

DES (15)

Chang et al.
(2018)
(n=17)
De Witte et al.
(2015) (n=3)
Herbet et al.
(2019) (n=11)
Leote et al. (2020)
(n=19)

Mandonnet et al.
(2019)
(n=10)

Martino et al.
(2018)
(n=32)

Moritz-Gasser et
al. (2013) (n=8)
Motomura et al.
(2020)
(n=50)
Nakajima et al.
(2019)
(n=66)
Rofes et al. (2017)
(n=6)
Satoer et al.
(2018) (n=18)
Signorelli et al.
(2007)
(n=28)
Starowicz-Filip et
al. (2020)
(n=15)
Tomasino et al.
(2020)
(n-49)
Zemmoura et al.
(2015) (n=7)

-

DES/real time
neuropsychological
testing (RTNT) (49)
DES (7)

Bipolar electrode (50 ~ 60 Hz, pulse duration 0.2 ms);
amperage ranged from 2.5 to 10 mA, stimulus for 4 seconds
Bipolar electrode (50 Hz, pulse duration 1ms), amperage
ranged from 6 to 12 mA
Bipolar electrode (60 Hz, pulse duration 1 ms), amplitude
began at 1 mA and increased 0.5- to 1 mA until the threshold
for after discharges were established by eCoG
Amperage ranged from 2mA to 25mA

-

GT (14), ST (6),
SpT (13)
GT (27), ST (11),
SpT (28)
Mean 69% (3.1291.33%)
GT (22), ST (6),
fatality (1)
-

Mean 93.16%
(R:45-100%)
Bipolar electrode (60 Hz, pulse length 1 ms) amplitude
ranged from 1.5 to 4 mA, stimulation of each site lasted
maximum 3 s.
(60 Hz, pulse duration 1 ms), amplitude ranged from 2 to 4
mA

-

“Adequate psych, profile
DES (16)
SpT (33)
and attitude”; no language
deficit, confusion, and/or
anxiety disorders; no
anesthesiologic contraindication
DES= Direct electrical stimulation, iUS= intraoperative ultrasound, nfMRI= navigated functional magnetic resonance imaging, iMRI= intraoperative
magnetic resonance imaging, eCoG= electrocorticography; VM= group with verbal memory assessed during AC; No VM= group not assessed with
verbal memory during AC; GT = gross total; ST = subtotal; SpT = supratotal

Zigiotto et al.
(2020)
(n=16)

a

Study criterion, not specific to participation in AC
reported
* From citation (Martino et al., 2015)

b 28

received language mapping; 73 received motor mapping only

c

Rest not
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Language Assessments/Tasks Associated with Awake Mapping
Pre- and Post-Operative Assessment
Pre- and post- operative language measures are summarized in Table 4. Of 37
language assessments, the most frequently used were verbal fluency tasks (n=9 studies),
the DO-80 (n=7 studies), the Boston Diagnostic Aphasia Test/short form
(BDAE/sfBDAE, n=4 studies), the Pyramids and Palm Trees Test (PPTT, n= 4 studies),
the Wechsler Adult Intelligence Scale/3rd Ed (WAIS/WAIS-III, n= 4 studies), and
unspecified naming tests (n= 4 studies). One study did not specify the language
assessment measures used but did use a well-known rating scale (National Outcomes
Measurement System). Of the 21 language domains assessed peri-operatively, the most
common were naming (n=17 studies), verbal fluency (n=12 studies), reading (n=10
studies), auditory comprehension (n=10 studies), and semantics (n=10 studies). Of the 37
language measures, 29 (78%) were either a published test measure or replicable from the
report, 7 (19%) were deemed not replicable due to missing information, and one naming
test (05%) was inferred to use a published test but this was not explicitly stated or
reported. All studies administered at least one test both pre- and post-operatively; the
majority (n= 16) of studies administered multiple measures pre-/post- operatively, and 13
studies administered at least one measure at all three time points (pre-, post-, and intraoperatively). Only one study (Zemmoura et al., 2015) administered all measures used at
all three time points.
Intra-operative Assessment
Intra-operative language assessment data is summarized in Table 5. Eight studies
pre-operatively trained stimuli used in the intra-operative language assessments, while 11
did not specify whether pre-operative training was provided. Of the 26 intra-operative
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language assessment measures identified across studies, the most frequently reported
were counting (n= 12 studies), Pyramids and Palm Trees Test (n= 8 studies), the DO-80
(n=6 studies), unspecified naming tasks (n=9 studies), verbal fluency tasks (n=4 studies),
discourse (n=4 studies), and unspecified language comprehension tasks (n=4 studies). Of
the 18 language domains measured intra-operatively, the most commonly evaluated were
naming (n= 19 studies), automatic speech (n= 14 studies), semantics (n= 12 studies),
spontaneous speech (n= 6 studies), and reading (n= 6 studies). Of the 26 measures
identified across studies, the majority used published or replicable tests. However, for
these measures, five studies did not report replicable counting, six studies did not report
replicable naming tasks, one study did not report a replicable reading task, one study did
not report a replicable repetitions task, one study did not report a replicable verbal
fluency task, one study did not report a replicable discourse task, one study did not report
a replicable memory span task, and one study did not report a replicable “sentence
construction” task. Intra-operative language assessment stimuli were presented using a
computer or laptop (n=9 studies), “slides” (n=1 study), or presentation modality was not
reported (n= 9 studies).

22
Table 4
Pre- and post-operative Language Assessment
Study

Language Measures

Language Domains
Assessed as Designated by
Author(s)

Standardized/
Replicable (Y/No)

Time Points
Administered

Altieri et al.
(2019)
(n=23)

"Writing, motor speech, comprehension, expression,
reading, pragmatics, attention, memory, problem solving
and visuo-perceptive functions… scored with the NOMS
scale"
Boston Naming Test (BNT) (German)
Aachen Aphasia Test (AAT)
Rivermead Behavioral Memory Test
Verbal fluency (categorical)
DO-80
Verbal fluency
Batteria per l’Analisi dei Deficit Afasici (BADA)
Word comprehension test
DO-80
Pyramids and Palm Trees (PPTT)
Short form Boston Diagnostic Aphasia Exam- Chinese
(sfBDAE)
Boston Naming Test (BNT)*
DuLIP (subtests: language, memory, executive functions,
visuoperception)
Aachen Aphasia Test (AAT)
Naming test *unspecified; has 80 items

W, AC, R, O-attention, VM, Oproblem solving, O-visuoperception

No (but rated with NOMS)

Pre, Post

N
AC, W, Rep, R
VM, AC
VF
N
VF
Rep, R, W, N, AC, Rep, VM
AC
N
Sem
VR, Rep, AC, P

Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y

Pre, Post
Pre, Post, Intra-operative
Pre, Post
Pre, Post, Intra-operative
Pre, Post, Intra-operative
Pre, Post
Pre, Post
Pre, Post, Intra-operative
Pre, Post, Intra-operative
Pre, Post, Intra-operative
Pre, Post

N
VM, VR, O- Visuoperception

Y
Y

Pre, Post
Pre, Post, Intra-operative

AC, Rep, N, R, VF, SynG, P, Sem
N

Y
- *inferred Y

Pre, Post
Pre, Post

during fMRI: Semantic judgment (PALPA-Portuguese)
Syntactic judgment
Verbal fluency (categorical verb)
Neurological examination: Picture naming
Pyramids and Palm Trees Test (PPTT)
Verbal fluency (categorical verb)
DO-80
Verbal fluency (categorical)
Pyramids and Palm Trees Test (PPTT)
Mathematics
The Free and Cued Selective Reminding Test (FCSRT)
Stroop Color and Word Test (SCWT)
Pictures of Facial Affect
DO-80
Boston Diagnostic Aphasia Exam (BDAE)- Commands
Boston Diagnostic Aphasia Exam (BDAE)- Reading
Rey Auditory Verbal Learning Test (RAVLT)
WAIS-III Digit Span tests
Symbol Digit Modality Test (SDMT)
Stroop Color and Word Test (SCWT)

Sem
SynG
VF
N
Sem
VF
N
VF
Sem
Calc
VM
O-attention, O-executive function
O-emotion recognition
N
AC
R
VM
VM
O-mental flexibility
O-mental flexibility

Y
Y
No
Y
Y
No
Y
No
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y

Pre
Pre
Pre
Pre, Post, Intra-operative
Pre, Post, Intra-operative
Pre, Post
Pre, Post, Intra-operative
Pre, Post
Pre, Post, Intra-operative
Pre, Post
Pre, Post
Pre, Post
Pre, Post, Intra-operative
Pre, Post, Intra-operative
Pre, Post
Pre, Post
Pre, Post
Pre, Post
Pre, Post
Pre, Post

Bartha et al.
(2000)
(n=5)
Bello et al.
(2007) (n=88)

Chang et al.
(2018)
(n=17)
De Witte et al.
(2015)
(n=3)
Herbet et al.
(2020) (n=11)
Leote et al.
(2020)
(n=19)

Mandonnet et
al. (2019)
(n=10)

Martino et al.
(2018)
(n=32)
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Study

Language Measures

Language Domains
Assessed

Standardized/
Replicable (Y/No)

Time Points
Administered

Moritz-Gasser
et al. (2013)
(n=8)

DO-80
Pyramids and Palm Trees Test (PPTT)
Verbal fluency (semantic)
Wechsler Adult Intelligence Scale 3rd Ed. (WAIS-III)
Wechsler Memory Scale-Revised (WMS-R)

N
Sem
VF (Sem)
O-Verbal comprehension, Sem
VM, O-attention

Y
Y
Y
Y
Y

Pre, Post, Intra-operative
Pre, Post, Intra-operative
Pre, Post
Pre, Post
Pre, Post

Picture naming
WAIS III Picture arrangement task
2-back test
Expression recognition test
Battery for Analysis of Aphasic Deficits (BADA)
Naming tasks
Mental Deterioration Battery (MDB)
Stroop Color and Word Test (SCWT)
Verbal (and Spatial) Immediate Memory Span
Boston Naming Test (BNT)
Verbal fluency (semantic)
Spontaneous speech variables test

No
Y
Y
No
Y
Y
Y
Y
Y
Y
Y
Y

Pre, Post, Intra-operative
Pre, Post, Intra-operative
Pre, Post
Pre, Post
Pre, Post
Pre, Post, Intra-operative
Pre, post
Pre, post
Pre, post
Pre, Post
Pre, Post
Pre, Post

Boston Diagnostic Aphasia Exam (BDAE)
Montreal-Toulouse Aphasia Battery (MT-86)

N
Sem
VM
O-emotion recognition
N, VF, Rep, R
N
VM, AC, O-inhibition
R, O-attention
VM
N
VF
SS-corrections, incomplete sentences,
MLUw; Rep
N, Rep, Sem
R, W

Y
Y

Pre, Post, Intra-operative*
Pre, Post

Addenbrooke's Cognitive Examination (ACE III) (A)
Addenbrooke's Cognitive Examination (ACE III) (B)

VM, VF, Rep, SynG, AC, SS, N, R,
W, Calc, Sem

Y

Pre
Post

Naming task
Verbal fluency
Batteria per l’Analisi dei Deficit Afasici (BADA) reading
Tests of oral and ideomotor apraxia
WAIS Digit Span tests
Token Test
DO-80
Verbal fluency (Phonological and semantic)
Montreal-Toulouse Aphasia Battery (MT-86) Reading
Dissocizioni semantiche intercategoriali
Tre test clinic di recerca e produzione lessicale
Mental Deterioration Battery (MDB)
DO-80
Verbal fluency (semantic)

N
VF
R
P, VF
VM
AC
N
VF
R, W
N, AC
N, Sem
N
VF

Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
No

Pre, post
Pre, Post
Pre, Post
Pre, Post
Pre, Post
Pre, Post
Pre, Post, Intra-operative
Pre, Post, Intra-operative*
Pre, Post, Intra-operative
Pre, Post
Pre, Post
Pre, Post
Pre, Post, Intra-operative
Pre, Post

Motomura et
al. (2020)
(n=50)
Nakajima et
al. (2019)
(n=66)
Rofes et al.
(2017)
(n=6)

Satoer et al.
(2018)
(n=18)
Signorelli et
al. (2007)
(n=28)
StarowiczFilip et al.
(2020)
(n=15)
Tomasino et
al. (2020)
(n=49)

Zemmoura et
al. (2015)
(n=7)
Zigiotto et al.
(2020)
(n=16)

*inferred
‘-‘indicates missing or insufficient information
AS = automatic speech, N = naming, Rep = repetitions, P = phonology, SynG = syntax/grammar, VF = verbal fluency, AC= auditory comprehension, R = reading, W =
writing, VM = verbal memory, VR = verbal reasoning/judgement, Calc= calculation, SS = spontaneous speech, O = other, DuLIP= Dutch Linguistic Intraoperative
Protocol,
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Table 5
Intra-operative Language Assessment
Study

Pre-operative
Training of
Intraoperative
Items

Intra-operative
Assessment

Language Domains
Assessed

Standardized/
Replicable
(Y/No)

Presentation
Modality

Altieri et al.
(2019)
(n=23)
Bartha et
al. (2000)
(n=5)

-

Y

Leote et al.
(2020)
(n=19)

Y

Mandonnet
et al. (2019)
(n=10)

-

Martino et
al. (2018)
(n=32)
MoritzGasser et
al. (2013)
(n=8)
Motomura
et al. (2020)
(n=50)
Nakajima
et al. (2019)
(n=66)
Rofes et al.
(2017)
(n=6)
Satoer et al.
(2018)
(n=18)

-

AS
N
Sem
AS
N
Rep
VF
VM, AC
Sem, AC
SynG
AS
N
AC, Sem
AS
N
Sem
AS
(VF, N, Sem, Calc, Rep)*
SS
AS
N
Sem
R
AS
N
Sem
SS
AS
N
Sem
O-emotion recognition, VR
AS
N
VM, N, R
AS
N
Sem

No
Y
Y
Y
Y
Y
Y
No
No
No
No
Y
Y
No
Y
Y
No
Y
Y
Y
Y
Y
No
Y
Y
Y
No
No
Y
Y
Y
Y
Y
Y
Y
Y

C

Bello et al.
(2007)
(n=88)
Chang et
al. (2018)
(n=17)
De Witte et
al. (2015)
(n=3)
Herbet et
al. (2019)
(n=11)

Counting
DO-80
PPTT
Automatic speech
AAT Naming
AAT Repetition
Categorical fluency
Word-span memory
Language comprehension
Sentence construction
Counting
Naming
Comprehension task
Counting
DO-80
PPTT
Counting
Quick Mix Test/DuLIP
Discourse
Counting
DO-80
PPTT
Reading*
Counting
DO-80
PPTT
Discourse*
Counting *
Naming (DO-80?)
PPTT
Pictures of Facial Affect
Counting
Naming (DO-80?)
Verbal memory task
Counting
DO-80
PPTT

Y

N
VM
VM, O-spatial memory
N
VR; “mentalizing”
O-spatial memory
AS
N
N, SynG
N
Rep
(P, Sem, SynG)
SS
N
VF
AC
R
SS

No
Y
Y
Y
Y
Y
Y
Y
No
No
Y
Y
Y
Y
No
Y

C

Signorelli
et al. (2007)
(n=28)

Naming
Digit span
Visual n-back test
Naming
WAIS-III Pic arranging
Spatial 2-back test
Counting
Naming
Producing finite verbs
Naming
Repetitions
Selected DuLIP
Discourse
Naming (BDAE?)
Word fluency
Comprehension tasks
Sentence reading *
Scene description *

-

Y

Y

-

Y

-

-

Y

-

-

C

-

C

C

-

-

- “slides”

-

-

C

-

C
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Study

Pre-operative
Training of
Intraoperative
Items

Intra-operative
Assessment

Language Domains
Assessed

Standardized/
Replicable
(Y/N)

Presentation
Modality

StarowiczFilip et al.
(2020)
(n=15)

-

AS
N
VF
AC

Y
No
-

-

Tomasino
et al. (2020)
(n=49)

Y

Zemmoura
et al. (2015)
(n=7)

-

Zigiotto et
al. (2020)
(n=16)

-

Automatic speech
Naming (ACE III?)
Verbal fluency
Speech comprehension (ACE
III?)
Discourse
BADA naming
Repetition
P &P discrimination
Digit span
BADA reading
Picture description
Counting
DO-80
MT-86
PPTT
Counting
Laiacona-Capitani
PPTT
Verb generation
Reading the Mind in the Eyes
Stroop test
Reading test

SS
N
Rep
P
VM
R
SS
AS
N
R, P, Sem
Sem
AS
N
Sem
N
O-emotion recognition
O-attention
R

No
Y
No
No
Y
Y
No
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y

C

C

-

*Performed for selective patients
‘-‘ indicates insufficient information; was counted as unspecified task and non-replicable
P&P Discrimination=phonemic and phonological discrimination; AAT = Aachen Aphasia Test; BADA = Batteria per l’Analisi del Deficit
Afasico; ACE-III = Addenbrooke’s Cognitive Examination III; DO-80 = Test de denomination oracle d’images; PPTT = Pyramids and Palm
Trees Test; DuLIP = Dutch Linguistic Intraoperative Protocol; WAIS-III = Wechsler Adult Intelligence Scale Third Edition; MT-86 =
Montreal- Toulouse Aphasia Battery; BDAE = Boston Diagnostic Aphasia Examination

AS = automatic speech, N = naming, Rep = repetitions, P = phonology, SynG = syntax/grammar, VF = verbal fluency,
AC= auditory comprehension, R = reading, W = writing, VM = verbal memory, VR = verbal reasoning/judgement,
Calc= calculation, SS = spontaneous speech, O= other(-specified)
C = computer/laptop
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Language Outcomes Following Awake Mapping
Language outcomes are summarized in Table 6. From the available data, during
the pre-operative period language impairments were reported in domains of naming
(n=55), phonology (n=8), repetition (n=3), semantics (n=5), verbal fluency (n=16),
auditory comprehension (n=3), verbal memory (n= 16), verbal reasoning (n=1), attention
(n=1), reading (n=8), and general language (n=61). During the acute post-operative
period (immediate through 3 months post), there was a general increase of participants
with impairments in the domains of phonology (n=12), repetition (n=4), semantics (n=
19), verbal fluency (n= 27), auditory comprehension (n=4), syntax and grammar (n=1),
reading (n=35), writing (n=2), attention (n=7), visuospatial perception (n=9), verbal
reasoning (n= 2), and higher cognition (inhibition, “mentalizing”) (n=13); a decrease
compared to pre-operative baselines in the number of participants with impairments in
domains of naming (n=34) and general language (n= 113); and no overall change in
verbal memory (n=21)). Of the available data, long-term (three months post-operative
and beyond) outcomes compared to baseline showed a greater number of persons with
documented impairments in the domains of cognitive mentalizing (n=1), semantics (n=7),
syntax and grammar (n=1), reading (n=12), writing (n=1), and visuospatial perception
(n=6); a decrease in number of individuals with impairment in the domains of naming
(n=10), phonology (n= 3), verbal fluency (n=9), auditory comprehension (n= 2), verbal
memory (n=8), and general language (n=27); and no change in the domain of repetitions
(n=3) and attention (n=1).
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Six studies indicated that language therapy took place during the post-operative
stage. Of the 104 patients reported as working professionally prior to tumor resection, 92
(88%) were able to return to work.
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Table 6
Language Outcomes Following Awake Mapping
Study

Language Domain

Pre-operative
(Total Impaired /Total
BTS)

Acute Postoperative (1Dup to 3M)
(Total
Impaired
/Total BTS)

Long-term
(3M+) (Total
Impaired /Total
BTS)

Post-operative
Language Therapy
Reported (Y/No)

Altieri et al
(2019)
(n=23)

AC
VM
W
R
O-attention
O-problem-solving
O-visuoperception
N (BNT)
Rep
P
VF
AC
W
R
VM
General language

6 (avg NOMS)
6
7
6
6
6
6
4/5
1/5
2/5
5/5
1/5
2/5
4/5
2/4
59/88 new or
worsened
3/88
1/88
6/19
2/19
1/3
1/3
2/3
2/3
1/3
1/3
1/3
2/11
1/11
4/19

7 (avg NOMS)
6
7
7
7
7
7
1/5
3/5
16/88 mild, 2/88
moderate or severe
1/88
1/88
1/3
1/3
1/3
1/3
1/3
1/3
1/3
2/19

No

VF
P
Rep
Sem
N
Sem
VM, VR, Rep, AC, P
N
Rep
Sem
VF
AC
VM
VR Visuoperception
N
Sem
General language

7 (avg group NOMS score)
7
7
7
7
7
7
1/5
1/5
3/5
4/5
23/88 “mild language
deficit”
1/19*
1/19*
1/19*
1/11
6/19

N
VF
Sem, VM
O-attention
O-emotion recognition
N
General language

29/32
3/32

5/12
6/12
3/12
6/12
2/12
12/32 new/ worse

2/32

No

N
Sem, VM
VF, P
General language

2/8
4/8
6/8
1/6
2/6
5/6
2/6
1/6
-

4/8
5/8
3/8
- 50/50 improved
from pre-operative
5/66
1/66
1/6
1/6
2/6
1/6
1/6
1/6
-

No

N
VM
O-visuospatial
O-mentalizing
N
Rep
N/SynG (finite verbs)
VM
AC
W
O-attention
O-inhibition/VR

7/8
7/8
6/8
15/50 “speech
disturbance”
3/66
3/66
8/66
10/66
2/6
2/6
1/6
5/6
2/6
1/6
1/6

Bartha et al.
(2000)
(n=5)

Bello et al. (2007)
(n=88)

Chang et al.
(2018)
(n=17)
De Witte et al.
(2015)
(n=3)

Herbet et al.
(2018) (n=11)
Leote et al.
(2020) (n=19)
Mandonnet et al.
(2019)
(n=10)

Martino et al.
(2018)
(n=32)
Moritz-Gasser et
al. (2013)
(n=8)
Motomura et al.
(2020) (n=50)
Nakajima et al.,
(2019)
(n=66)
Rofes et al.
(2017)
(n=6)

Y-reported patients
received none

No

No

Y

Y
No

Y

No
No

No

29
Study

Satoer et al.
(2018) (n=18)

a

Signorelli et al.
(2007)
(n=28)

Starowicz-Filip
et al. (2020)
(n=15)
Tomasino et al.
(2020)
(n=49)

Language Domain

Pre-operative
(Total Impaired /Total BTS)

Acute Postoperative (1D-up to
3M) (Total
Impaired /Total
BTS)

Long-term (4M+)
(Total Impaired
/Total BTS)

Post-operative Language
Therapy Reported
(Y/No)

N
VF
Incomplete sentences
MLUw
General language

BTS group mean
BTS group mean
BTS group mean
5/28 Mixed aphasia
7/28 nonfluent aphasia
5/8 memory deficit
12/28 “expression
difficulty”
-

BTS group mean
BTS group mean
BTS group mean
BTS group mean
17/28
6/28
comprehension

BTS group mean
BTS group mean
BTS group mean
BTS group mean
5/28 expression or
comprehension
“troubles”

No

-

2/28
2/15

R
N

8/49 (object), 12/49 (verb)
7/49
7/49
2/49
-- (39.3% mean accuracy
on REY)
1/7

No

No
26/49
5/33
Zigiotto et al.
-(23.8% mean
- (42% mean
Y
(2020) (n=7)
accuracy on REY)
accuracy on REY)
Zemmoura et al.
N
4/7
2/7
Y
(2015)
P
3/7
(n=7)
Sem
4/7
VF
5/7
2/7
R
5/7
5/7
W = weeks, M = months, NOMS= National Outcomes Measurement System, AS = automatic speech, N = naming, Rep =
repetitions, P = phonology, SynG = syntax/grammar, Sem = semantics, VF = verbal fluency, AC= auditory comprehension, R =
reading, W = writing, VM = verbal memory, VR = verbal reasoning/judgement, Calc= calculation, SS = spontaneous speech; Oother; MLUw= mean length of utterance, number of words; ‘-‘ indicates all patents normal functioning or not reported
REY= rey-osterith memory tests (complex figure, 15-word recall, 15-word repetitions list)
*Rest not reported
a

N
VF
R
VM
VM

No

Only group data reported; not individualized results
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Quality of Evidence
The quality of evidence for individual studies is reported in Table 7. According to
Academy of Neurologic Communication Disorders and Sciences (ANCDS, 2006)
classifications (see Appendix E), study designs were controlled group design (CGD, n= 6
studies), case series (uncontrolled with data not averaged across cases) (n=3),
uncontrolled group (UG, n= 4), randomized control trial (RCT, n=1), correlational study
(Corr, n=1), and single participant design (SPD, n=4). According to the American
Academy of Neurology (AAN, 2007) level of evidence scale (corresponding with the
research design type), studies included evidence level 3 (n=8 studies), level 2 (n=10
studies), and level 1 (n=1 study). The mean ASHA QI score (max = 9) was 4.68 (SD=
1.003, range= 3-6). The mean RoBINT score (max= 30) was 8.86 (SD=1.77, range= 611), and the mean PEDro score (max= 10) was 5.67 (SD= 0.78, range= 4-7).
Table 7
Quality Indicator Scores
Study (n)

AAN* Research
Design Type

AAN *Level
of Evidence

Altieri et al.
(2019)
(n= 23)
Bartha et al.
(2000)
(n=5)
Bello et al.
(2007)
(n=88)
Chang et al.
(2018)
(n=17)
De Witte et al.
(2015)
(n=3)
Herbet et al.
(2019)
(n=11)
Leote et al.
(2020)
(n=19)
Mandonnet et
al. (2020)
(n=10)

CGD

2

ASHA QI
Score
(max = 9)
4

Case Series

3

CGD

RoBINT
(max = 30)

PEDro
(max = 10)

NA

6

4

9

NA

2

6

NA

6

UG

3

3

NA

6

Case Series

3

3

7

NA

CGD

2

6

NA

6

RCT

1

6

NA

7

Case Series

3

5

10

NA
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Martino et al.
(2018)
(n=32)
Moritz-Gasser
et al. (2013)
(n=8)

CGD

2

6

NA

6

SPD

2

5

10

NA

Study

AAN* Research

AAN *Level

RoBINT

PEDro
(max = 10)

Design Type

of Evidence

ASHA QI
Score
(max = 9)

CGD

2

5

NA

4

Corr

3

4

NA

5

SPD

2

5

11

NA

UG

3

5

NA

5

SPD

2

4

6

NA

UG

3

4

NA

5

UG

3

4

NA

6

SPD

2

4

9

NA

CGD

2

6

NA

6

Motomura et al.
(2020)
(n=50)
Nakajima et al.
(2019)
(n=66)
Rofes et al.
(2017)
(n=6)
Satoer et al.
(2018)
(n=18)
Signorelli et al.
(2007)
(n=28)
Starowicz-Filip
et al. (2020)
(n=15)
Tomasino et al.
(2020)
(n=49)
Zemmoura et
al. (2015)
(n=7)
Zigiotto et al.
(2020)
(n=16)

(max = 30)

*Scale from 1-3, with 1 being the highest level
NA = Not applicable
UG= uncontrolled group, Corr= correlational, SPD= single participant design, CGD= controlled group design, RCT=
randomized control trial

Discussion
To be included in this review, articles were required to include at least one patient
older than 18 with a diagnosis of brain tumor; identify the neuroimaging technique(s)
used during awake craniotomy; include intra-operative assessment of at least three
language domains using at least one standardized and/or replicable measure; and report
post-operative language outcome data using at least one standardized language
assessment. 19 studies met these criteria. This discussion begins by summarizing the
primary research findings and then reviews demographic characteristics, intra-operative
neuroimaging techniques, language tests and domains assessed pre-, post-, and intra-
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operatively, short- and long-term post-surgical language outcomes, as well as the overall
quality of this research.
Patient demographic information varied widely, as did tumor characteristics,
though the majority of tumors were located in left peri-sylvian areas. The majority of
participants had mild-moderate language impairments prior to resection; this and the fact
that some studies excluded participants with pre-existing language impairments is likely
due to the fact that the purpose of language mapping during AC is to preserve existing
language abilities.
Direct electrical stimulation (DES) was used in all of the included studies, and
five studies included additional supplemental neuroimaging methods. Peri-operatively,
the majority of measures were published and/or replicable and most assessed the
language domains of naming, verbal fluency, reading, auditory comprehension, and
semantics. The measures used to assess these and other language domains varied widely.
Intra-operatively, a slightly less wide range of language assessments were used than those
used peri-operatively, but more of these measures were not published/replicable. The
most common domains assessed intra-operatively were naming, automatic speech,
semantics, spontaneous speech, and reading. Language outcomes showed an overall
increase in language impairment during the acute (up to three months post-operative)
recovery phase compared to baseline (pre-operative), followed by a general lessening of
deficits. The most common deficits identified long term (beyond three months postoperative), were in areas of general language, naming, verbal fluency, verbal memory,
and semantics. The majority of the articles included in this review were designated as low
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levels of evidence (AAN classifications two and three); however, one study was
designated as a randomized control trial (AAN classification level one).
Patient Demographics and Brain Tumor Characteristics
One interesting finding is the geographic areas of recruitment for the included
studies. The majority of studies were completed in Europe (n=16), with the remaining
studies originating from Asia (n=3). This is not to say that DES and intraoperative
language mapping assessments are not used in other parts of the world (e.g., North or
South America), but rather that research from these countries has not focused on
language assessment/outcomes (e.g., Almeida et al., 2014; Brown et al., 2020), did not
meet study inclusion criteria (e.g., Shen et al., 2019; Shields & Choucair, 2014), and/or
may not yet be published.
In keeping with the fact that 16 of the included articles recruited patients from
Europe, most participants spoke Italian, French, or other European languages. Most of the
participants did not use English as their first language. Only one participant in one study
is explicitly stated as being a monolingual English speaker (Zemmoura et al., 2015). A
second participant, from the same study, was described as French-English bilingual. Of
the six articles that reported languages spoken by patients (n=121), 71 (58.7%) spoke
Italian. This is particularly interesting given that English, then Mandarin Chinese, are the
most frequently-spoken languages in the world (Szmigiera, 2021).
As expected, the majority of patients had left hemisphere and/or peri-sylvian
tumors; but not all. In addition, relative to other studies, participants had a higher-thanexpected number of tumors restricted to the frontal lobe (38.6%), compared to parietal
lobe (8.49%) or temporal lobe (21%). Though many tumors classified as diffuse (n=80)
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also extended into the parietal lobe (28/80, 35%). The findings reported here are largely
consistent with a recent report by Hall et al. (2021) of 469 patients treated with awake
craniotomy. In their study, tumor location was identified as frontal lobe (47%), parietal
lobe (22.8%), and temporal lobe (17.9%) (Hall et al., 2021).
Compiling data for tumor grade and malignancy proved difficult due to variance
in level of detail reported across studies. Four studies reported tumor grade as only
“high” or “low” grade rather than the more detailed WHO grade classifications, while
some of this data was selectively reported or not reported at all. However, given that low
grade (grades I and II) tumors are generally slower-growing and more benign than the
more malignant higher grade (grades III and IV) tumors, it could be stated that this study
included 220 “more benign” tumors and 189 “more malignant” tumors, with 62 either not
reported or between stages II and III.
Neurosurgical Procedures Associated with Awake Language Mapping
Only four studies stated conditions determining a patient’s candidacy for awake
craniotomy, as opposed to other treatment (e.g., surgery under general anesthesia or
“asleep” surgery). Two additional articles had study inclusion criteria that provided
insight into the conditions that might prevent patients from undergoing awake resection.
Of the reported conditions from these four studies, eight considerations centered on
mental or behavioral factors (e.g., excluding individuals that did not meet criteria on
psychological or language measures) and seven centered on physical or medical factors
(e.g., excluding young or very elderly individuals or patients with intracranial pressure).
However, the fact that the majority of articles included in this review did not specify

35
factors limiting patient candidacy for AC decreases the usefulness of these studies for
clinicians in determining candidacy for their own patients.
Though DES was used for language mapping in all of the included studies, a wide
range of complementary imaging techniques (intra-operative ultrasound, navigated
functional magnetic resonance imaging, intra-operative magnetic resonance imaging,
electrocorticography) were included in this sample. None of these supplemental
techniques were favored over another by study count. This attests to the variety of
imaging methods available and the unique data and information each technique provides
(Gandhe & Bhave, 2018; Caras et al., 2020; Cirillo et al., 2019).
One of the most consistent aspects of the data collected was the DES stimulation
process. Though there were some small variances in amplitude and duration of
stimulations, many have converged on the extensive, well-known work of Wilder
Penfield and George Ojemann (Berger et al., 1990; Ojemann et al., 1989; Penfield &
Boldrey, 1937; Tarapore et al., 2012). The stimulation procedure is fairly standardized.
Language Assessments/Tasks Associated with Awake Mapping
In contrast to the well-standardized DES procedures described above, intraoperative procedures for behavioral language assessment are still in development. There
is large variability in the number of measures used and the language domains assessed,
with little justification for selecting particular measures or domains.
Naming, automatic speech (e.g., counting), and verbal fluency were among the
most common domains of language assessed intra-operatively. This overlaps in part with
findings by Martin-Mendoza et al. (2020), who found that naming, reading aloud, and
generating verbs were the most common intra-operative tasks. The difference in reported
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findings could be attributed to differences between classifications/terminology used in the
two reviews. This study classified all confrontational naming, including generation of
verbs from pictures, within the general domain of “naming” rather than separating object
or action naming. In addition, our criteria of requiring a minimum of three intra-operative
measures excluded a significant number of studies.
Recommendations for Clinical Application
The articles included in this review had several clinical recommendations for
selecting intra-operative language measures. Rofes et al. (2017) recommended a naming
task that includes both object naming and finite verb production over either naming task
alone, as their study found the combined naming to be more thorough. They also
recommended using standardized measures with normative data when possible, though
warned that normative data may be based on clinical populations that do not include brain
tumor patients (Rofes et al., 2017). Chang et al. (2018) found that the Pyramids and Palm
Trees Test had greater sensitivity and specificity in predicting post-operative language
deficits, compared to the DO-80, though intra-operative performance on both intraoperative measures correlated with accuracy in the post-operative language measure (the
sfBDAE). Zemmoura et al. (2015) found that phonological and reading tasks were critical
for mapping areas in specific locations such as the posterior portion of the inferior
longitudinal fascicule. This coincides with the recommendation by De Witte et al. (2015)
that tumor location should be taken into account when selecting intra-operative language
assessments. Inclusion of measures assessing other neurocognitive functions, such as
digit span tests (Motomura et al., 2020) and verbal memory tests (Martino et al., 2018)
was also recommended to prevent significant decline of post-surgical abilities in these
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areas. Mapping of subcortical areas was also recommended (Bello et al., 2007), as this
was associated with a lower incidence of persistent long-term language impairments,
albeit with a higher incidence of transient impairment in the acute post-operative phase.
Satoer et al. (2018) recommended evaluating multiple linguistic levels during intra- and
peri-operative assessment. It appears that the best intra-operative measures are
personalized to tumor location, assess a wide range of language domains, and assess
language ability at multiple linguistic levels. Selection of language measures that best
meet these criteria requires further research and development.
These recommendations come from studies rated as level 2 according to the AAN
(2017) levels of evidence, with the exception of the studies by Satoer et al. (2018) and
Chang et al. (2018), which were level 3 studies.
Language Outcomes Following Awake Mapping
As expected, language outcomes showed a general pattern of increased
impairment during the acute phase (immediate post-operative through three months post),
followed by general improvement of language functions in long-term assessments
compared to baseline (pre-operative measures) The exception to this was the study by
Satoer et al. (2018), which showed the greatest decline in the average ability of the brain
tumor survivor group between three months post- operative and the one-year follow up.
However, as noted by the authors, this “is not in line with most cognitive outcome
studies” (p. 115). This result was attributed to possible tumor recurrence. The overall
long-term language impairments reported in Satoer et al.’s (2018) study were still
considered to be mild.
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The most common long-term (persisting longer than three months) language
impairments were in the areas of general language (n=17), reading (n=12), naming
(n=10), verbal fluency (n=9), and verbal memory (n=8). This is largely in agreement with
previous reports (Brownsett et al., 2019; Chang et al., 2015; Papagno et al. 2016; Wilson
et al., 2015). Though naming has been called the most frequently occurring postoperative impairment (Chang et al., 2015; Wilson et al., 2015), presenting deficits are
likely dependent upon location of the tumor. This may partly explain our findings of
higher occurrence of long-term impairment in reading over naming. Specifically, longterm deficit in naming has been associated with resection of temporal lobe areas (Krauss
et al., 1996; Wilson et al., 2015). Our findings showed a higher occurrence of tumor in
frontal and parietal rather than temporal areas.
There was considerable overlap between the language domains assessed (periand intra-operatively) and the domains of language with long-term impairments. This
finding, summarized in Table 8 below, provides some support for the content validity of
the selected language measures. Greater overlap was found between peri-operative (vs.
intra-operative) measures and persistent language impairments. This is to be expected
because it is the post-operative measures that detect and score post-operative language
deficits. However, the domains of naming and reading are both frequently assessed intraoperatively and both are among the most common long-term impairments.
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Table 8
Persistent Language Impairments Compared to Most Commonly Assessed Domains
Language Domains
Most Commonly Assessed Peri-Operatively Naming, Verbal Fluency, Reading, Auditory
Comprehension, Semantics
Most Commonly Assessed IntraNaming, Automatic Speech, Semantics,
Operatively
Spontaneous Speech, Reading
Most Common Persistent (longer than 3
General language, Reading, Naming, Verbal
months post-operative) Language
Fluency, Verbal Memory
Impairments

An additional item of note concerning language outcomes is the sensitivity of
measures used to detect possible impairments. Satoer et al. (2018) observed, “Most
linguistic variables did not correlate with standardized tests usually administered in
glioma patients. A spontaneous speech analysis seems to be more sensitive than
standardized language tests for the detection of (surgery induced) language deficits until
long-term” (p. 115). A higher incidence of post-operative language deficits has been
found to be correlated with the existence of pre-surgical language deficits (Clavreul et al.,
2021; Rolston et al., 2015) and possibly how extensive the post-operative language
assessments are, as suggested by Brownsett et al. (2019).
Future studies investigating the extent to which identification of long-term
language impairments are linked to variables such as those above (e.g., tumor location,
pre-surgical language impairment, psychometric properties of language measures, such as
content validity and test sensitivity) are still needed to further guide clinicians in selecting
appropriate measures.
Quality of Evidence
With the exception of one randomized control trial (RCT), the majority of the
studies were classified as intermediate or low-level evidence. That said, the studies
included in this review represent the highest available evidence for intra-operative
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language assessment of brain tumor survivors. Relative to other studies, strengths
included reporting pre-, post, and intra-operative language status with at least one
standardized and/or replicable measure (as per the inclusion criteria), reporting statistical
significance for primary study findings, and describing awake craniotomy/language
mapping (treatment) procedures. Generally, randomization and blinding of
participants/assessors were weak points of the included studies, again with the exception
of the randomized control trial. Many group studies did not have control groups or clearly
defined control conditions.
Contribution
Previous related reviews covered literature up to 2016. This review shows that most
recent literature is responding to recommendations made by previous reviews evaluating
intra-operative language assessment practices (DeWitte & Marien, 2013; Martin-Monzon
et al., 2020; Rofes & Miceli, 2014; Ruis, 2018; Zanin et al., 2017). This study compiles
updated information on state-of-the-art practices for patient candidacy, intra-operative
neuro-imaging procedures, and clinical recommendations for intra-operative language
assessment, with the majority of included studies being published after 2016. In addition,
this review not only looked at the most commonly-used assessments (Martin-Monzon et
al., 2020; Ruis, 2018) but also evaluated the language domains assessed and the language
outcomes following surgical procedure. Our findings found that more extensive language
assessment is occurring and is even being encouraged by clinicians implementing this in
practice, but that there may still be a need for using more standardized assessments intraoperatively.
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Interest in this topic continues to expand, as shown in the descendent search.
Though almost all of the articles identified through this search method did not meet our
inclusion criteria, many of them from most recent years focused on language assessments
specific to brain tumor or intra-operative language assessment and/or norming of new
experimental protocols. As research continues to develop, more research may include
standardized protocols more appropriate for this population.
Limitations
This study is limited in that the electronic search was only for the years 20142021. However, this limitation was partially offset by including articles identified in
previously published reviews (DeWitte & Marien, 2013; Martin-Monzon et al., 2020;
Rofes & Miceli, 2014; Ruis, 2018; Zanin et al., 2017) covering the literature back to
1976. Moreover, neuroimaging, and specifically intra-operative language assessment,
have evolved rapidly since the first intraoperative review/protocol for language
assessment was published. In addition, this review only reflects what is done in the
reported literature and not what is done in all treatment clinics. As more language
assessment batteries specifically for intra-operative use are being developed and tested,
follow-up reviews will provide further guidance and insight.
Conclusion
This review provides a broad overview of state-of-the-art intra-operative language
assessment practices for BT patients. A range of neuroimaging techniques and intraoperative language assessments were utilized across a broad range of patients with
diverse tumor characteristics. Value lies in looking at trends in current assessment
practices, analyzing the evidence, and considering the relations between demographic and

42
tumor characteristics, intra-operative procedures, and language outcomes. This
information is invaluable to both neurosurgeons and administrators of intra-operative
language assessments for making clinical decisions that will optimize best-of-care and
quality of life for BT patients.

43
References
Almeida J. P., Chaichana, K. L., Rincon-Torroella, J., & Quinonones-Hinojosa, A.
(2015). The value of extent of resection of glioblastomas: Clinical evidence and
current approach. Current Neurology and Neuroscience Reports, 15.
10.1007/s11910-014-0517-x
Altieri, R., Raimondo, S., Tiddia, C., Sammarco, D., Cofano, F., Zeppa, P., ... &
Barbagallo, G. (2019). Glioma surgery: From preservation of motor skills to
conservation of cognitive functions. Journal of Clinical Neuroscience, 70, 55-60
Alves, J., Cardoso, M., Morgado, M., De witte, E., Satoer, D., Hall, A., & Jesus, L. M.
(2020). Language assessment in awake brain surgery: the Portuguese adaptation
of the Dutch Linguistic Intraoperative Protocol (DuLIP). Clinical Linguistics &
Phonetics, 1-19. 10.1080/02699206.2020.1868022
Anderson, S. W., Damasio, H., & Tranel, D. (1990). Neuropsychological impairments
associated with lesions caused by tumor or stroke. Arch Neurol., 47(4), 397-405.
10.1001/archneur.1990.00530040039017
Bartha, L., Knsop, E., Pfisterer, W., & Benke, T. (2000). Intra- and perioperative
monitoring of language functions in patients with tumours in the left perisylvian
area. Aphasiology, 14(8), 779-793. 10.1080/026870300412205
Bello, L., Gallucci, M., Fava, M., Crarabba, G., Giussan, C., Acerbi, F., Baratta, P.,
Songa, V., Conte, V., Brancaa, V., Stocchetti, N., Papagno, C., & Gaini, S. M.
(2007). Intraoperative subcortical language tract mapping guides surgical removal
of gliomas involving speech areas. Neurosurgery, 60, 67-82.

44
Berger, M. S., Ojemann, G. A., & Lettich, E. (1990). Neurophysiological monitoring
during astrocytoma surgery. Neurosurgery Clinics of North America, 1(1), 65-80.
Brown, D. A., Hanalioglu, S., Chaichana, K., & Duffau, H. (2020).
Transcorticosubcortical approach for left posterior mediobasal temporal region
gliomas: A case series and anatomic review of relevant white matter tracts. World
Neurosurgery 139, E737-E747.
Brown, T. J., Brennan, M. C., Li, M., Church, E. W., Brandmeir, N. J., Rakszawski, K.
L., Patel, A. S., Rizk, E. B., Sawaya, R., & Glantz, M. (2016). Association of the
extent of resection with survival in glioblastoma: A systematic review and metaanalysis. JAMA Oncology, 2(11), 1460-1469. 10.1001/jamaoncol.2016.1373
Brownsett, S. L. E., Ramajoo, K., Copland, D., McMahon, K. L., Robinson, G.,
Drummond, K., Jeffree, R. L., Olson, S., Ong, B., & Zubcaray, G. D. (2019).
Language deficits following dominant hemisphere tumour resection are
significantly underestimated by syndrome-based aphasia measurements.
Aphasiology. 10.1080/-2687038.2019.1614760
Bu, L.-H., Zhang, J., & Wu, J.-S. (2020). Glioma surgery with awake language mapping
versus generalized anesthesia: A systematic review. Neurosurgical Review, 44,
1997-2011.
Buchfelder, M., & Zhao, Y. (2018). Is awake surgery for supratentorial adult low-grade
gliomas the gold standard? Neurosurgical Review, 41, 1-2. 10.1007/s10143-0170916-y

45
Caras, A., Mugge, L., Miller, W. K., Mansour, T. R., Schroeder, J., & Medhkour, A.
(2020). Usefulness and impact of intraoperative imaging for glioma resection on
patient outcome and extent of resection: A systematic review and analysis. World
neurosurgery, 134, 98-110.
Chan H.-M., Loh, W. N.-H., Yeo, T. T, & Teo, K. (2019). Awake craniotomy and
excision of a diffuse low-grade glioma in a multilingual patient: Neuropsychology
and language. World Neurosurgery, 128, 91-97.
Chang, E. F., Clark, A., Smith, J. S., et al. (2011). Functional mapping-guided resection
of low-grade gliomas in eloquent areas of the brain: improvement of long-term
survival. Journal of Neurosurgery, 114(3): 566–573. 10.3171/2010.6.JNS091246
Chang, W.-H., Pel, Y-C., Wei, K-C., Chao, Y.-P., Chen, M.-H., Yeh, H.-A., Jaw F.-S.,
Chan, P.-Y. (2018). Intraoperative linguistic performance during awake brain
surgery predicts postoperative linguistic deficits. Journal of Neuro-Oncology,
129, 215-223.
Cherney, L. R., Patterson, J. P., Raymer, A., Frymark, T., & Schooling, T. (2008).
Evidence-based systematic review: Effects of intensity of treatment and
constraint-induced language therapy for individuals with stroke-induced aphasia.
Journal of Speech, Language, and Hearing Research, 51(5), 1058-1381.
https://doi.org/10.1044/1092-4388(2008/07-0206)
Chikenzie, E., ReFaey, K., Garca, O., Raghuraman, G., & Quinones-Hinojosa, A. (2017).
Volumetric analysis of extent of resection, survival, and surgical outcomes for
insular gliomas. World Neurosurgery, 103, 265-274. 10.1016/j.wneu.2017.04.002

46
Cirillo, S., Caulo, M., Pieri, V., Falini, A., & Castellano, A. (2019). Role of functional
imaging techniques to assess motor and language cortical plasticity in glioma
patients: A systematic review. Neural Plasticity, 2019.
Clavreul, A., Aubin, G., Delion, M., Lemee, J.-M., Minassian, A. T., & Menei, P. (2021).
What effects does awake craniotomy have on functional and survival outcomes
for glioblastoma patients? Journal of Neuro-Oncology, 151, 113-121.
Davie, G. L., Hutcheson, K. A., Barringer, D. A., Weinberg, J. S., & Lewin, J. S. (2009).
Aphasia in patients after brain tumour resection. Aphasiology, 23(9), 1196-1206.
10.1080/02687030802436900
Deloche, G., & Hannequin, D. (1997). Test de dénomination orale d’images: DO 80. Ed
du Centre de psychologie appliquée.
De Witt Hamer, P. C., Robles, S. G., Zwinderman, A. H., Duffau, H., & Berger, M. S.
(2012). Impact of intraoperative stimulation brain mapping on glioma surgery
outcome: A meta- analysis. J Clin Oncol: 30(20), 2559-2565.
10.1200/JCO.2011.38.4818
De Witte, E., & Mariën, P. (2013). The neurolinguistic approach to awake surgery
reviewed. Clinical Neurology and Neurosurgery, 115(2013), 127-145.
10.1016/j.clineuro.2012.09.015
De Witte, E., Satoer, D., Robert, E., Colle, H., Verheyen, S., Visch-Brink, E., & Mariën,
P. (2015). The Dutch linguistic intraoperative protocol: a valid linguistic approach
to awake brain surgery. Brain and Language, 140, 35-48.

47
Dilmen, O. K., Akcil, E. F., Oguz, A., Vehid, H., & Tunali, Y. Comparison of conscious
sedation and asleep-awake-asleep techniques for awake craniotomy. Journal of
Clinical Neuroscience, 35, 30-34. 10.1016/j.jocn.2016.10.007
Dragoy, O., Chrabaszcz, A., Tolkacheva, V., & Buklina, S. (2016). Russian
intraoperative naming test: A standardized tool to map noun and verb production
during awake neurosurgeries. The Russian Journal of Cognitive Science, 3(4), 425
Dragoy, O., Zyrayanov, A., Bronov, O., Gordeyeva, E., Gronskaya, N., Kryuchkova, O.,
Klyuev, E., Kopachev, D., Medyanik, I., Mishnyakova, L., Pedyash, N., Pronin,
I., Reutov, A., Sitnikov, A., Stupina, E., Yashin, K., Zhirnova,V., & Zuev, A.
(2020). Functional linguistic specificity of the left frontal aslant tract for
spontaneous speech fluency: Evidence from intraoperative language mapping.
Brain and Language, 208(2020), 104836. 10.1016/j.bandl.2020.104836
Duffau, H. (2013). Brain mapping in tumors: Intraoperative or extraoperative? Epilepsia,
54(s9), 79-83. 10.1111/epi.12449
Duffau, H. (2015). Stimulation mapping of white matter tracts to study brain functional
connectivity. Nat Rev Neurology 5, 255-265. 10.1038/nrneurol.2015.51
Duffau, H. (2018). Is non-awake surgery for supratentorial adult low-grade glioma
treatment still feasible? Neurosurgical Review, 41, 133-139.
Dziedzic, T., & Bernstein, M. (2014). Awake craniotomy for brain tumor: Indications,
technique, and benefits. Expert Review of Neurotherapeutics, 14(12), 1405-1415.
10.1586/14737175.2014.979793

48
Gandhe R U, & Bhave C P (2018). Intraoperative magnetic resonance imaging for
neurosurgery—an anesthesiologist’s challenge. Indian Journal of Anaesthia,
62(6): 411-417. 10.4103/ija.IJA_29_18
Globocan. (Nov. 2020). World Fact Sheets. World Health Organization [infographic].
Retrieved February 5, 2021, from
https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf
Groshev, A., Padalia, D., Patel, S., Garcia-Getting, R., Sahebjam S., Forsyth, P. A.,
Vrionis, F. D., & Etame, A. B. (2017). Clinical outcomes from maximum-safe
resection of primary and metastatic brain tumors using awake craniotomy.
Clinical Neurology and Neurosurgery, 157, 25-30.
10.1016/j.clineuro.2017.03.017
Hall, S., Kabwama, S., Sadek, A.-R., Dando,A., Roach, J., Weidmann, C., & Grundy, P.
(2021). Awake craniotomy for tumour resection: The safety and feasibility of a
simple technique. Interdisciplinary Neurosurgery, 24. 10.1016/j.inat.2020.101070
Herbet, G., Moritz-Gasser, S., Lemaitre, A.-L., Almairac, F, & Duffau, H. (2019).
Functional compensation of the left inferior longitudinal fasciculus for picture
naming. Cognitive Neuropsychology, 36(3-4), 140-157.
10.1080/02643294.2018.1477749
Howard, D., & Patterson, K. E. (1992). The Pyramids and Palm Trees Test: A test of
semantic access from words and pictures. Thames Valley Test Company.

49
John Hopkins Medicine. (2021). Types of Brain Tumor Surgery. Brain Tumor Center.
https://www.hopkinsmedicine.org/neurology_neurosurgery/centers_clinics/brain_
tumor/treatment/surgery/index.html
Kanno, A., & Mikuni, N. (2015). Evaluation of language function under awake
craniotomy. Neurologia Medico-Chirurgica, 55(5), 367-373.
10.2176/nmc.ra.2014-0395.
Kelm, A., Sollmann, N., Ille, S., Meyer, B., Ringel, F., & Krieg, S. M. (2017). Resection
of gliomas with and without neuropsychological support during awake
craniotomy—effects on surgery and clinical outcome. Frontiers in Oncology,
18(7). 10.3389/fonc.2017.00176
Krauss, G. L., Fisher, R., Plate, C., Hart, J., Uematsu, S., Gordon, B., & Lesser, R. P.
(1996). Cognitive effects of resecting basal temporal language
areas. Epilepsia, 37(5), 476-483
Lagomkin, N., & Hadjipanayis, C. G. (2018). Flourescence-guided surgery for highgrade gliomas. Journal of Surgical Oncology, 118, 356-361. 10.1002/jso.25154
Leal, R. T. M., da Fonseca, C. O., & Landeiro, J. A. (2017). Patients’ perspective on
awake craniotomy for brain tumors—single center experience in Brazil. Acta
Neurochirurgica, 159, 725-731. 10.1007/s00701-017-3125-0
Leote, J., Loucao, R., Viegas, C., Lauterbach, M, Perez-Hick, A., Monteiro, J., Nunes, R.,
& Ferreira, H. A. (2020). Impact of navigated task-specific fMRI on direct
cortical stimulation. Journal of Neurological Surgery A, 555-564.

50
Louis, D., N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D.,
Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W.
(2016). The 2016 World Health Organization Classification of Tumors of the
Central Nervous System: A Summary. Acta Neuropathologica, 131, 803-820.
10.1007/s00401-016-1545-1
Mandonnet, E., Herbet, G., & Duffau, H. (2020). Letter: Introducing new tasks for
intraoperative mapping in awake glioma surgery: Clearing the line between
patient care and scientific research. Neurosurgery, 86(2), E256-E257.
10.1093/neuros/nyz447
Mandonnet, E., Sarubbo, S., & Duffau, H. (2017). Proposal of an optimized strategy for
intraoperative testing of speech and language during awake mapping.
Neurosurgical Review, 40, 29-35. 10.1007/s10143-016-0723-x
Mandonnet, E., Winkler, P. A., & Duffau, H. (2010). Direct electrical stimulation as an
input gate into brain functional networks: Principles, advantages, and limitations.
Acta Neurochirurgica, 152, 185-193. 10.1007/s00701-009-00469-0
Martín-Monzón, I., Ballagas, Y. R., & Arias-Sánchez, S. (2020). Language mapping: A
systematic review of protocols that evaluate linguistic functions in awake surgery.
Applied Neuropsychology: Adult, 10.1080/23279095.2020.1776287
Martino J., Gomez, E., Marco de Lucas, E., Mato, D., Vazquez-Bourgon, J. (2018).
Intraoperative identification and preservation of verbal memory in diffuse
gliomas: A matched-pair cohort study. Neurosurgery, 83, 1209-1218.

51
Martino, J., Mato, D., de Lucas, E. M., García-Porrero, J. A., Gabarrós, A., FernándezCoello, A., & Vázquez-Barquero, A. (2015). Subcortical anatomy as an
anatomical and functional landmark in insulo-opercular gliomas: Implications for
surgical approach to the insular region. Journal of Neurosurgery, 123(4), 10811092. 10.3171/2014.11.JNS141992
McFaline-Figueroa, R., & Lee, E. Q. (2018). Brain Tumors. The American Journal of
Medicine, 131(8), 874-882. 10.1016/j.amjmed.2017.12.039
McGirt, M. J., Mukherjee, D., Chaichana, K. L., Than, K. D., Weingart, J. D., &
Quinones-Hinojosa, A. (2009). Association of surgically acquired motor and
language deficits on overall survival after resection of glioblastoma multiforme.
Neurosurgery, 65(3), 463-470. 10.1227/01.NEU.0000349763.42238.E9
Meng, L., Berger, M. S., & Gelb, A. W. (2015). The potential benefits of awake
craniotomy for brain tumor resection: An anesthesiologist’s perspective. Journal
of Neurosurgical Anethesiology, 27(4). 10.1097/ana.0000000000000179
Miceli, G., Capasso, R., Monti, A., Santini, B., & Talacchi, A. (2012). Language testing
in brain tumor patients. Journal of Neuro-Oncology, 108, 247-252.
Miceli G., Laudanna A., Burani, C., Capasso, R. (1994). Batteria per l’analisi dei deficit
afasici, Milano: CEPSAG, Universita Cattolica del Sacro Cuore.
Moritz-Gasser, S., Herbet, G., & Duffau, H. (2013). Mapping the connectivity underlying
multimodal (verbal and non-verbal) semantic processing: A brain
electrostimulation study. Neuropsychologia, 51, 1814-1822.

52
Motomura, K., Chalise, L., Ohka, F., Aoki, K., Tanahashi, K., Hirano, M., Nishikawa, T.,
Yamaguchi, J., Shimizu, H., Wakahayashi, T., & Natsume, A. (2020).
Neurocognitive and functional outcomes in patients with diffuse frontal lowergrade gliomas undergoing intraoperative awake brain mapping. Journal of
Neurosurgery, 132, 1683-1691.
Murray, L., Salis, C., Martin, N., & Dralle, J. (2018). The use of standardized short-term
and working memory tests in aphasia research: a systematic review.
Neuropsychological Rehabilitation, 28(3), 309-351.
10.1080/09602011.2016.1174718
Nagaya, T., Nakamura, Y. A., Choyke, P. L., & Kobayashi, H. (2017). Flourescenceguided surgery. Frontiers in Oncology, 7, 314. 10.3389/fonc.2017.00314
Nakajima, R., Kinoshita, M., Okita, H., Yahata, T., & Nakada, M. (2019). Glioma
surgery under awake condition can lead to good independence and functional
outcome excluding deep sensation and visuospatial cognition. Neuro-oncology
Practice, 6(5), 354-363.
Noll, K. R., Bradshaw, M. E., Parsons, M. W., Dawson, E. L., Rexer, J., & Wefel, J. S.
(2019). Monitoring of neurocognitive function in the care of patients with brain
tumors. Current Treatment Options of Neuro-oncology, 21(33). 10.1007/s11940019-0573-2
Nossek, E., Matot, I., Shahar, T., Barzilai, O., Rapoport, Y., Gonen, T., Sela, G., Korn,
A., Hayat, D., & Ram, Z. (2013). Failed awake craniotomy: A retrospective

53
analysis in 424 patients undergoing craniotomy for brain tumor. Journal of
Neurosurgery, 118(2), 215-488. 10.3171/2012.10.JNS12511
Ohlerth, A.-K., Valentin, A., Vergani, F., Ashkan, K., & Bastiaanse, R. (2020). The verb
and noun test for peri-operative testing (VAN-POP): Standardized language tests
for navigated transcranial magnetic stimulation and direct electrical stimulation.
Acta Neurochirurgica, 162, 397-406 (2020). 10.1007/s1007/s00701-019-04159-x
Ojemann, G., Ojemann, J., Lettich, E. R. E. E. G. T., & Berger, M. (1989). Cortical
language localization in left, dominant hemisphere: an electrical stimulation
mapping investigation in 117 patients. Journal of neurosurgery, 71(3), 316-326.
O’Neill, M., Henderson, M., Duffy, O. M., & Kernohan, W. G. The emerging
contribution of speech and language therapists in awake craniotomy: A national
survey of their roles, practices and perceptions. International Journal of
Language & Communication Disorders, 55(1), 149-162. 10.1111/14606984.12510
Ostrom, Q. T., Gittleman, H., Truitt, G., Boscia, A., Kruchko, C., & Barnholtz-Sloan, J.
S. (2018). CBTRUS Statistical report: Primary brain and other central nervous
system tumors diagnosed in the United States in 2011-2015. Neuro-Oncology,
20(S4), 1-86. 10.1093/neuronc/noy131
Ottenhausen, M., Krieg, S. M., Meyer, B., & Ringel, F. (2015). Functional preoperative
and intraoperative mapping and monitoring: Increasing safety and efficacy in
glioma surgery. Journal of Neurosurgery 38(1), E3.
10.3171/2014.10.FOCUS14611

54
Papagno, C., Casarotti, A., Comi, A., Pisoni, A., Luccheli, F., Bizzi, A., Riva, M., &
Bello, L. (2016). Long-term proper name anomia after removal of the uncinate
fasciculus. Brain Structure and Function, 221, 687-694. 10.1007/s00429-0140920-8
Penfield, W., & Boldrey, E. (1937). Somatic motor and sensory representation in the
cerebral cortex of man as studied by electrical stimulation. Brain, 60(4), 389-443.
Raeke, M. (April 2018). Awake craniotomy for brain tumors: 8 questions. MD Anderson
Cancer Center. Retrieved February 12, 2021, from
https://www.mdanderson.org/cancerwise/awake-craniotomy-for-brain-tumors--8questions.h00159223356.html#:~:text=You%20could%20be%20awake%20for,symptoms%20y
ou%20had%20before%20surgery.
Raffa, G., Quattropani, M. C., & Germano, A. (2019). When imaging meets
neurophysiology: The value of navigated transcranial magnetic stimulation for
preoperative neurophysiological mapping prior to brain tumor surgery. Journal of
Neurosurgery, 47(6). 10.3173/2019.9.FOCUS19640
Rittacio, A. L., Brunner, P., & Schalk, G. (2018). Electrical stimulation mapping of the
brain: Basic principles and emerging alternatives. Journal of Clinical
Neurophysiology, 35(2), 86-97. 10.1097/WNP.0000000000000440
Rofes, A., Mandonnet, E., Godden, J., Baron, M. H., Colle, H., Darlix, A., de Aguiar, V.,
Duffau, H., Herbet, G., Klein, M., Lubrano, V., Martino, J., Mathew, R., Miceli,
G., Moritz-Gasser, S., Pallud, J., Papagno, C., Rech, F., Robert, E., … &Wager,

55
M. (2017). Survey on current cognitive practices within the European Low-Grade
Glioma Network: Towards a European assessment protocol. Acta Neurochir, 159,
1167-1178. 10.1007/s00701-017-3192-2
Rofes, A., & Miceli, G. (2014). Language mapping with verbs and sentences in awake
surgery: a review. Neuropsychology Review, 24(2), 185-199.
Rofes, A., Spena, G., Talacchi, A., Santini, B., Miozzo, A., & Miceli, G. (2017).
Mapping nouns and finite verbs in left hemisphere tumors: a direct electrical
stimulation study. Neurocase, 23(2), 105-113.
Rolston, J. D., Englot, D. J., Benet, A., Li, J., Cha, S., & Berger, M. S. (2015). Frontal
operculum gliomas: language outcome following resection. Journal of
neurosurgery, 122(4), 725-734.
Ruis, C. (2018). Monitoring cognition during awake brain surgery in adults: A systematic
review. Journal of Clinical and Experimental Neuropsychology, 40(10), 10811104. 10.1080/13803395.2018.1469602
Rutten, G. J. M., Ramsey, N. F., van Rijen, P. C., Noordmans, H. J., & Van Heelen, C.
W. M. (2002). Development of a functional magnetic resonance imaging protocol
for intraoperative localization of critical temporoparietal language areas. Annals of
Neurology, 51(3), 350-360. 10.1002/ana.10117
Sacko, O., Lauwers-Cances, V., Brauge, D., Sesay, M., Brenner, A., & Roux, F.-E.
(2011). Awake craniotomy vs surgery under general anesthesia for resection of
supratentorial lesions. Neurosurgery, 68(5), 1192-1199.
10.1227/NEU.obo13e31820c02a3

56
Saito, T., Muragaki, Y., Maruyama, T., Tamura, M., Nitta, M., & Okada, Y. (2015).
Intraoperative functional mapping and monitoring during glioma surgery.
Neurologia Medico Chirurgica (Tokyo), 55(1), 1-13. 10.2176/nmc.ra.2014-0215
Sanai, N., & Berger, M. S. (2010). Intraoperative stimulation techniques for functional
pathway preservation and glioma resection. Journal of Neurosurgery. 28(2).
10.3171/2009.12FOCUS09266
Sanai, N., & Berger, M. S. (2018). Surgical oncology for gliomas: The state of the art.
Nature Reviews Clinical Oncology, 15(2).
http://dx.doi.org.dist.lib.usu.edu/10.1038/nrclinonc.2017.171
Sanai, N., Mirzadeh, Z., & Berger, M. S. (2008). Functional outcome after language
mapping for glioma resection. New England Journal of Medicine, 358(1), 18-27.
Satoer, D., Vincent, A., Ruhaak, L., Smits, M., Dirven, C., & Visch-Brink, E. (2018).
Spontaneous speech in patients with gliomas in eloquent areas: Evaluation until 1
year after surgery. Clinical Neurology and Neurosurgery, 167, 112-116.
Satoer, D., Visch-Brink, E., Dirven, C. et al. (2016). Glioma surgery in eloquent areas:
can we preserve cognition? Acta neurochiruigica. 158(35).
https://doi.org/10.1007/s00701-015-2601-7
Schlosser, R. W., Wendt, O.., & Sigafoos, J. (2007). Not all systematic reviews are
created equal: Considerations for appraisal. Evidence-Based Communication
Assessment and Intervention, 1(3), 138-150.

57
Sefcikova, V., Sporrer, J. K., Ekert, J. O., Kirkman, M. A., & Samandouras, G. (2020).
High interrater variability in intraoperative language testing and interpretation in
awake brain mapping among neurosurgeons or neuropsychologists: An emerging
need for standardization. World Neurosurgery, 141, e651-e660.
10.1016/j.wneu.2020.05.250
Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P.,
Stewart, L. A., & PRISMA-P Group. (2015). Preferred reporting items for
systematic review and meta-analysis protocols (PRSMA-P) 2015: Elaboration and
explanation. Bmj, 349, g7647.
Shen, E., Calandra, C., Geralemou, S., Page, C., Davis, R., Andraous, W., & Mikell, C.
(2019). The Stony Brook awake craniotomy protocol: A technical note. Journal of
Clinical Neuroscience, 67, 221-225.
Shields, L. B. E., & Choucair, A. K. (2014) Management of low-grade gliomas: A review
of patient-perceived quality of life and neurocognitive outcome. World
Neurosurgery, 82(1/2), E299-E309. 10.1016/jwnau.2014.01.033
Signorelli, F., Ruggeri, F., Iofrida, G., Isnard, J., Chirchiglia, D., Lavano, A., ... &
Guyotat, J. (2007). Indications and limits of intraoperative cortico-subcortical
mapping in brain tumor surgery: an analysis of 101 consecutive cases. Journal of
Neurosurgical Sciences, 51(3), 113-128.
Simmons-Mackie, N., Raymer, A., Armstrong, E., Holland, A., & Cherney, L. R. (2010).
Communication partner training in aphasia: A systematic review. Archives of
physical medicine and rehabilitation, 91(12), 1814-1837.

58
Starowicz-Filip, A., Prochwicz, K., Myszka, A., Krzyzewski, R., Stachura, K., Chrobak,
A. A., Rajtar-Zembaty, A. M., Betkowska-Korpala, B, & Kwinta, B. (2020).
Subjective experience, cognitive functioning and trauma level of patients
undergoing awake craniotomy due to brain tumor- Preliminary study. Applied
Neuropsychology: Adult, 1-10. 10.1080/23279095.2020.1831500
Szelényi, A., Bello, L., Duffau, H., Fava, E., Feigl, G. C., Galanda, M., Neuloh, G.,
Signorelli, F., & Sala, F. (2010). Intraoperative electrical stimulation in awake
craniotomy: Methodological aspects of current practice. Neurosurgical Focus
FOC, 28(2), E7. 10.3171/2009.12.FOCUS09237
Szmigiera, M. (2021, March 30). The Most Spoken Languages Worldwide 2021. Statista.
https://www.statista.com/statistics/266808/the-most-spoken-languagesworldwide/
Talacchi, A., d’Avella, D., Denaro, L., Santini, B., Meneghelli, P., Savazzi, S., & Gerosa,
M. (2012). Cognitive outcome as part and parcel of clinical outcome in brain
tumor surgery. Journal of Neuroncology, 108, 327-332. 10.1007/s11060-0120818-3
Tarapore, P. E., Chang, E. F., & Berger, M. S. (2012). Intra-operative imaging techniques
during surgical management of gliomas. US Neurology, 7(2), 163-168.
10.17925/USN.2011.07.02.163
Tomasino, B., Lus T., Skrap, M., & Luzzati, C. (2020). Phonological and surface
dyslexia in individuals with brain tumors: Performance pre-, intra-, immediately
post-surgery and at follow-up. Human Brain Mapping, 41, 5015-5031.

59
Watt, A. (2018). A systematic review of language therapy in pediatric brain tumor
survivors [Unpublished master’s thesis]. Utah State University.
Wilson, S. M., Lam, D., Babiak, M. C., Perry, D. W., Shih, T., Hess, C. P., Berger, M. S.,
& Chang, E. F. (2015). Transient aphasias after left hemisphere resective surgery.
Journal of Neurosurgery, 123(3), 581-593. 10.3171/2015.4.JNS141962
Xia, L., Fang, C., Chen, G., & Sun, C. (2018, January 6) Relationship between the extent
of resection and the survival of patients with low-grade gliomas: A systematic
review and meta-analysis. BMC Cancer (18) 48. 10.1186/s12885-017-3909-x
Zanin, E., Riva, M., Bambini, V., Cappa, S. F., Magrassi, L., & Moro, A. (2017). The
contribution of surgical brain mapping to the understanding of the anatomofunctional basis of syntax: A critical review. Neurological Sciences, 35, 15791589.
Zemmoura, I., Herbet, G., Mortiz-Gasser, S., & Duffau, H. (2015). New insights into the
neural network mediating reading processes provided by cortico-subcortical
electrical mapping. Human Brain Mapping, 36, 2215-2230.
Zigiotto, L., Annicchaarico, L., Corsini, F., Vitali, L., Falchi, R., Dalpiaz, C., Rozzanigo,
U., Barbareschi, M., Avesani, P., Papagno, C., Duffau, H., Chioffi, F., & Sarubbo,
S. (2020). Effects of supra-total resection in neurocognitive and oncological
outcome of high-grade gliomas comparing asleep and awake surgery. Journal of
Neuro-Oncology, 145, 97-108.

60

Appendices

61
Appendix A. Study Inclusion Form
(adapted from Rajinder & Koul, 2015; and Watt, 2018)
Abbreviated Reference:

Coder:

Date:

STEP 1. Initial screen for inclusion: Please read through the list of publication titles (and
abstracts if needed) in Rayyan. If the answer is clearly ‘No’ to ANY of the questions
listed below, enter your rationale for exclusion (only enter the first reason for exclusion)
in Rayyan using the number and letter codes listed below. If the answer to ALL questions
could be ‘Yes’ (i.e., you are undecided and need more information), then continue with
step 2.

STEP 2. Second screen for inclusion: Retrieve the full article and read as much of the
article as necessary to make a decision. If the answer is ‘No’ to ANY of the questions
listed below, enter your rationale for exclusion using the number and letter codes listed
below.

Criteria for Inclusion
1. Is the full publication printed/available in English?
If ‘No,’ enter 1 In Rayyan for Reason excluded. For Label enter the language
(e.g., “Spanish”)

2. Was the article published between 2014-June 2021?
Notes:
● Articles will be included if any version of the publication was
published after 2014.
Reasons for Exclusion:
2a) The publication was not published within the specified time
frame.

In Rayyan for Reason excluded enter 2a. For Label enter the year of
publication.

Y or N
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3. Was the article published in a peer-reviewed journal and does it contain
original research?
Notes:
● Systematic reviews will be excluded. In Rayyan, mark relevant
reviews as ‘maybe’ so that they can be referenced in the introduction.
Reasons for Exclusion:
3a) The publication was not published in a peer-reviewed journal.
3b) Publication is a review of previously published research (relevant
publications will be referenced in the introduction/discussion and
checked for references).
3c) Publication is a duplicate (e.g., exact duplicate or online/hard
copy reference of a publication that has already been referenced).

In Rayyan for Reason excluded enter 3a, 3b, or 3c.
4. Was the publication an experimental or quasi-experimental study (e.g., small
n or single participant design including pre-/post treatment designs,
controlled group design, randomized control trials, or meta-analysis) or a
correlational study comparing the relation between pre-/intra- and posttreatment variables?
Notes:
● Refer to page 11 of the manual for more information regarding single
participant designs (e.g., multiple baseline design across participants,
behaviors, contexts; alternating treatment designs; multiple probe
designs; withdrawal/reversal designs; changing criterion designs),
controlled group designs, randomized control trials, and metaanalyses.
● The following non-experimental (no control group, condition, or
phase) studies will be excluded: Single case studies/case reports;
position papers; expert opinion; best practice recommendations.
● Retrospective studies of patient records can be included.
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If ‘no’, enter 4 in Rayyan for Reason excluded.

5. Participants: Does the study include at least one adult patient or participant
(over 18 years of age) with diagnosis of brain tumor?
Notes:
● The tumor(s) may be anywhere in the brain (cerebrum, cerebellum,
or brainstem).
● Cases with co-morbidities (stroke/seizures) and/or cases receiving
concurrent medical treatments (e.g., chemotherapy/radiation) may be
included.
● Metastases are to be included.
● Stroke subsequent to brain tumor excision may be included if there
was at least one follow-up of language between resection and stroke.
Reasons for Exclusion:
5a) Participant(s) are in the wrong age group (<18 years), and/or this
is a cadaver/autopsy, immunohistology, or genetic tissue study.
5b) None of the participants have a diagnosis of brain tumor (e.g.,
there is no diagnosis of tumor and/or the tumor is in the spinal cord
and/or outside the CNS).
5c) Brain tumor is not the primary diagnosis. The study focuses on
another pathology. (e.g., one or more participants have an additional
diagnosis of brain tumor, but little information is given about the
tumor and/or focus is on another primary condition)

In Rayyan for Reason excluded, enter 5a, 5b, or 5c.
6. Intervention: Does the publication identify the intra-operative neuroimaging
technique(s) used?
Notes:
● This includes publications that do not exclusively focus on intraoperative imaging.
Reasons for Exclusion:
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6a) The publication does not state that intra-operative imaging was
used OR imaging was not intra-operative.
6b) No specific intra-operative imaging method (e.g., direct
electrocortical stimulation/direct electrical stimulation (DES),
electrocorticography (ECoG), fluoroscopy, intraoperative MRI
(iMRI)) is given in the publication.

In Rayyan for Reason excluded enter 6a or 6b.
7. Intervention: Does the publication include intra-operative assessment of
naming (e.g., confrontation or picture object and/or action naming) and at
least two other tasks assessing the following:
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Automatic speech (e.g., counting)
Reading
Writing
Spontaneous speech
Auditory comprehension
Syntax/grammar
Phonology
Semantics (e.g., sorting, picture-word matching)
Repetitions
Timed fluency tasks (generative naming and/or speech efficiency)
Bilingual speakers (e.g., naming in multiple language/code switching)
Calculation
Verbal memory
Verbal reasoning/judgement

Notes:
● Publications can focus on neuroimaging and/or medical/behavioral
variables.
Reasons for Exclusion:
7a) The publication does not include any description of intraoperative assessment, or the assessment(s) are not of language (e.g.,
the study includes assessment of motor functions but not language).
7b) Only one or two domains of language processing is assessed
(e.g., naming).
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In Rayan for Reason excluded enter 7a or 7b.
8. Intervention: Is at least one of the intra-operative language assessments/tasks
(see examples listed above) a standardized test and/or an experimental task
that is replicable (i.e., a published measure and/or adequate description in the
study of administration, cueing, stimuli, scoring, and interpretation
procedures allowing for replication)?
If ‘No,’ enter 8 for Reason excluded in Rayyan.
9. Outcomes: Does the study report post-operative language outcome data
using at least one standardized language assessment (e.g., WAB-R, BDAE-3,
SCCAN, BNT, MoCA, etc.)?
If ‘No,’ enter 9 in Rayan for Reason excluded.
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Appendix B. PsychInfo Search Terms
(language OR speech OR apraxia OR aphasia OR communication OR "auditory
comprehension" OR listening OR reading OR writing OR conversation OR discourse OR
naming OR "word retrieval" OR "sentence production" OR "sentence comprehension"
OR grammar OR linguistics OR semantics OR spelling OR linguistic OR "action
naming" OR "verbs and sentences" OR “spontaneous speech” OR eloquent OR dyslexia
OR “reading comprehension” OR alexia)
AND (resection OR "awake craniotomy" OR "awake surgery" OR
neuronavigation OR "intra-operative imaging" OR neurosurgery OR craniotomy OR
"direct electrocortical stimulation" OR " intra-operative magnetic resonance imaging" OR
"direct electrical stimulation" OR "intra-operative stimulation mapping" OR "cortical
stimulation" OR "intra-operative monitoring" OR "diagnostic imaging" OR "intraoperative neurophysiological monitoring")
AND (glioma OR tumor OR cancer OR astrocytoma OR ependymoma OR glial
OR glioblastoma OR malignant OR meningioma OR medulloblastoma OR metastasis OR
oligodendroglioma OR oncology OR chondrosarcoma OR craniopharyngioma OR cyst
OR hemangioma OR hemangioblastoma OR hemangiopericytoma OR lipoma OR
lymphoma OR neurofibromatosis OR oligoastrocytoma OR schwannoma)
AND (evaluation OR assessment OR test OR task OR "standardized test battery"
OR analysis OR tool OR protocol OR screening OR measure OR "mapping diagnostic"
OR monitoring OR examine OR investigate OR probe OR questionnaire OR standardized
OR "non standardized" OR appraising OR "neuropsychological tests" OR “mental status
test”)
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AND (brain OR cerebral OR cortical OR subcortical OR “frontal lobe” OR “parietal
lobe” OR “temporal lobe” OR occipital OR limbic OR thalamic OR cranial OR “central
nervous system” OR “arcuate fasciculus” OR “longitudinal fasciculus” OR “posterior
cingulate cortex” OR “uncinate fasciculus” OR “fronto-occipital fasciculus” OR
“parietopontine” OR “cingulate cortex”)
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Appendix C. Web of Science Search Terms
TS=(language OR speech OR apraxia OR aphasia OR communicat* OR "auditory
comprehension" OR listening OR reading OR writing OR conversation OR discourse OR
naming OR "word retrieval" OR "sentence production" OR "sentence comprehension"
OR grammar OR linguistics* OR semantics* OR spelling OR "action naming" OR "verbs
and sentences" OR “spontaneous speech” OR eloquent OR dyslexia OR “reading
comprehension” OR alexia)
AND (resection OR "awake craniotomy" OR "awake surgery" OR
neuronavigation* OR "intra-operative imaging" OR neurosurgery OR craniotomy OR
"direct electrocortical stimulation" OR " intra-operative magnetic resonance imaging" OR
"direct electrical stimulation" OR "intra-operative stimulation mapping" OR "cortical
stimulation" OR "intra-operative monitoring" OR "diagnostic imaging" OR "intraoperative neurophysiological monitoring")
AND (glioma OR tumor* OR cancer OR astrocytoma OR ependymoma OR glial
OR glioblastoma OR malignant OR meningioma OR medulloblastoma OR metastasi$s
OR oligodendroglioma OR oncology OR chondrosarcoma OR craniopharyngioma OR
cyst OR hemangioma OR hemangioblastoma OR hemangiopericytoma OR lipoma OR
lymphoma OR neurofibromatosis OR oligoastrocytoma OR schwannoma)
AND (evaluation OR assessment OR test OR task OR "standardized test battery"
OR analysi$s OR tool OR protocol OR screening OR measure OR "mapping diagnostic"
OR monitoring OR examine OR investigate* OR probe OR questionnaire OR
standardized* OR "non-standardized" OR appraising* OR "neuropsychological tests" OR
“mental status test”)
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AND (brain OR cerebral OR cortical OR subcortical OR “frontal lobe” OR
“parietal lobe” OR “temporal lobe” OR occipital OR limbic OR thalamic OR cranial OR
“central nervous system” OR “arcuate fasciculus” OR “longitudinal fasciculus” OR
“posterior cingulate cortex” OR “uncinate fasciculus” OR “fronto-occipital fasciculus”
OR “parietopontine” OR “cingulate cortex”)
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Appendix E: Manual for Rating Intraoperative Brain Tumor
Survivor (BTS) Language Assessment Studies
Inclusion Criteria: To be included in the evidence table, publications must:
1. Be written in English
2. Be published in a peer-reviewed journal and contain original research. Reviews will
be excluded.
3. Be an experimental, quasi-experimental, or correlational pre/intra- and postcraniotomy study.
4. Include at least one adult (over 18 years) patient or participant with a diagnosis of
brain tumor.
5. Identify the intra-operative neuroimaging technique used during awake craniotomy.
6. Include Intraoperative assessment of at least three of the following language
domains: Naming, automatic speech, reading, writing, spontaneous speech, auditory
comprehension, syntax/grammar, phonology, semantics, repetitions, timed fluency
tasks, bilingual tasks, verbal memory, verbal reasoning/judgement. Studies that focus
on pre-surgical assessment and/or incidentally mention speech/language assessment
following the surgery without intraoperative evaluation and/or comment on its
effectiveness but provide no evidence regarding what assessment took place should
be excluded.
7. Assess intraoperative language using (at least) one standardized test and/or
experimental task that is replicable.
8. Report post-operative language outcome data using at least one standardized
language assessment.
*Year criterion (2014-2021) was only used for electronic search
See Appendix A (Study Inclusion Form) for more detailed information about inclusion/exclusion
criteria.

Instructions for entering information from treatment studies into the Table of
Evidence
Introduction
This manual is designed to make data extraction easier and to facilitate inter-coder
reliability. First, data extraction roughly follows the order in which information is
presented in a typical research article. Specifically, the coding manual and accompanying
excel spreadsheet are divided into 13 broad sections:
I.
General coding of publication and raters (Columns A-C)
II.
Citation/Reference (Columns D-H)
III.
Study Overview - Abstract (Columns I-L)
IV.
Language/Communication Assessment Research Questions or Objectives Introduction (Column M)
V.
Participant Population– General—Methods/Results (Columns N-P)
VI.
Participant Demographics: Brain Tumor Survivors only (Columns Q-AK)
VII. Pre-operative Language Assessment (Columns AL-AT)
VIII. Intraoperative Mapping and Resection: Technical - Methods (Columns
AU-BA)
IX.
Intraoperative Language Ax for BTS (Columns BB-BQ)
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X.
XI.
XII.
XIII.

Post-Operative Language Outcomes (Columns BR-CF)
XI. Quality of Evidence for Study (Columns CG-CN)
Conclusions- Results/Discussion/Conclusions (Columns CO-CU
Ancestral Search – Reference (Column CV)

Second, since some study information may be presented in multiple locations in a
publication (with variable levels of detail/consistency), guidelines are provided for each
section/variable, indicating where to retrieve specific study information. For instance, at
the start of section IV. Research Questions or Objectives, the guidelines specify that this
information should be extracted (when possible) from the Introduction section of the
article, or if not available in the Introduction, the information should be extracted from
other sections of the publication that provide the most relevant information. This is
summarized in the guidelines below by a ‘go to’ arrow followed by the preferred
information source/article section (→INTRODUCTION).
In addition, codes are used to make data extraction easier, facilitate inter-coder reliability,
and support future data analyses. As detailed below, letters (usually the first letter of a
key word) are used to code categorical data, such as gender (e.g. M = male; F= female) or
outcomes. Codes can also have suffixes that provide more detailed information about the
initial code. For example, with respect to outcome codes, an improvement (I) in the
target behavior that was statistically significant (SS), would be transcribed as: I-SS. For
single subject designs with more than one participant, a second suffix is used to indicate
the number of participants associated with each category (e.g. D-NS-1; I-SS-1; I-NS-1)
(averages are used for group studies).
The following general codes are used for all variables:
O-specify
Use capital letter ‘O’ to indicate ‘Other’ ie. information relevant to
a particular variable that is not captured by the available codes
and/or if quantitative information is requested (e.g. age) but only
descriptive information is provided (e.g. ‘older adults’). The “O”
should be followed by a dash and explanation.
Examples
i.With respect to aphasia classification, there is no code for
isolation aphasia, so this would be entered as “O-isolation
aphasia”.
ii. With respect to years of education, if the only information
provided was the inclusionary criteria that participants had a
minimum of 9 years of education, you would enter as “Oinclusionary criteria: participants had at least 9 yrs of education”.
NA
Use NA to indicate that information is not relevant for a particular
study (e.g., if you are evaluating a group study, you would enter
‘NA’ in column CA (which asks for a quality rating of single
subject designs).
.
Use the period symbol to denote missing data (information that is
not reported in the publication under review). Do NOT leave any
cells empty. The ‘.’ code serves two functions. First, it clarifies for
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you and others that the entry was actually coded (vs.
overlooked/skipped accidentally). Second, it allows excel to read
this information as missing when computing any statistics (e.g.,
means, SD, etc.).
*
If you have a question/comment about any information that is
entered that you would like to discuss with other reviewers, put an
asterisk in the column and then enter your question/comment in
that column.
?
If you have a question about something that is ambiguous in the
publication AND you think that this could be clarified by
contacting study authors, add the question mark symbol at the end
of the entry, and then enter your question in column BW (Question
for study authors).
When entering descriptive information, be as specific as possible with respect to
terminology e.g., enter ‘recurrent medulloblastoma’ (vs. ‘tumor’).
Medical terminology: If you are uncertain about terminology in the publication, go to the
following reference cite for clarification:
https://www.merriam-webster.com/medical
I. General coding of publication and raters (columns A-C)
A. Study number (assigned in advance by project lead)
B. Rater 1 (assigned in advance by project lead)
C. Rater 2 (assigned in advance by project lead)
Citation/Reference (Columns D-H)
D. Citation – enter full reference using APA style without indenting
E. First author – enter last name of first author
F. Year – enter year of publication
G. Title of publication – enter title of publication
H. Journal – enter name of journal
III. Study Overview (Columns I-L) →ABSTRACT
This section is meant to capture broad information about the study. In most cases it will
correspond to information about the surgical procedure, but in some cases, the purpose,
participants, results, and/or interpretation will be broader than the language assessment.
For example, the purpose may be to assess the effectiveness of a general procedure to
maximize extent of resection for brain tumor survivors (that includes information about
the intraoperative speech/language assessment).
I. Purpose/rationale – provide a 1 sentence summary of the authors’ stated
purpose/rationale for the study. For example: To examine the effects of direct electrical
stimulation on the left frontal aslant (variable x) on articulation (target
language/communication assessment/behavior y).
J. Participant description – enter the number of participants, age range, and the
diagnoses (e.g., 5 adults with a mean age of 49 yrs and dx of aphasia).
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K. Results –Summarize (in 1-2 sentences) the primary outcome(s) as reported by study
authors (e.g., Treatment x resulted in statistically significant improvement in extent of
resection for awake craniotomy over general anesthesia).
L. Author’s Interpretation – Summarize (in 1-2 sentences) the authors’ conclusions (e.g.,
Treatment x may be a feasible assessment protocol for awake craniotomy)
IV. Language/Communication Research Questions or Objectives (Column M)
→INTRODUCTION
This section covers specifics related to the language and/or speech assessment (as
opposed to other medical/general rehabilitation).
M. Research Questions/Objectives specific to language/communication tx – Briefly list
up to three most important research questions/objectives related to intraoperative imaging
or intraoperative language assessment (1 sentence/question). Example: Was intraoperative assessment X effective in preserving language outcomes?
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V. Participant Population (Columns N-P) →METHODS/RESULTS
This section covers specifics related to the patients that participated in awake craniotomy
language mapping (as opposed to other medical/general treatments). If no information is
provided, code as missing data (i.e., enter “.”)
Most of this information will be described in detail in the METHODS section. However,
if there is a discrepancy between what was planned (METHODS section) and what was
actually done (RESULTS section) record what was actually done (usually this will be in
the RESULTS section).
N. Number of participants total - Enter the total number of treated participants in the
study (regardless of participant group (e.g., awake craniotomy vs. general anesthesia).
O. Number of participants with dx other than brain tumor – Enter the number of treated
participants who did NOT have a diagnosis of brain tumor. If all treated participants had
a brain tumor enter the number “0”.
P. Diagnoses other than brain tumor – List the primary medical diagnoses of
participants and (if available) the number of participants with each diagnosis (e.g.,
epilepsy-3). If all participants had a brain tumor enter ‘NA’.
VI. Participant Demographics: Brain Tumor Survivors only (Columns Q-AL)
→METHODS/RESULTS
This section covers specifics related to participants who received awake craniotomy
speech/language assessment (as opposed to other medical/general rehabilitation). If no
information is provided, code as missing data (i.e., enter “.”).
Most of this information should be provided in the Methods section of the article.
However, if there is a discrepancy between information in the Methods and Results
section (e.g. a discrepancy between inclusionary/exclusionary criteria in the Methods and
characteristics of the final sample as presented in the Results) enter the information that
you think most accurately reflects the characteristics of the sample that
Q. Number of BT Survivors – Enter the number of participants with a history of brain
tumor.
R. BTS/Total – Enter the proportion of BTS participants relative to other participants
(e.g., 8/12).
S. Age –Enter the age (in years) of the participant at the start of the study. If a study
involves multiple BTS participants, enter the average age of these participants.
T. Age Range – Enter the minimum and maximum ages (e.g., 18-76). If min-max is not
available, enter the most closely related descriptive information (e.g., Inclusionary
criteria: Participants were between 21-85 years of age).
U. Gender – Specify gender using the codes:
M = male
F = female
Specify the number of participants in each category (e.g., M-2; F-1).
V. Education –Enter the average years of education at the start of the study.
W. Education Range – For studies with more than one BTS participant, enter the
minimum and maximum years of education (e.g., 12-23). If only descriptive data is
provided about education (for individuals/groups), the descriptive information should be
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entered in this column (e.g., minimum high school education; all participants were
literate native-speakers of English).
X. Employment Status - Enter the employment status of participants at the start of the
study using the codes:
W = working
S = student
D= currently on disability leave
R = Retired
O = Other- specify
If available, provide more specific information about employment (e.g., W-teacher)
For studies with more than one BTS participant, specify the number of participants in
each category (e.g., W-1; D-3).
Y. Time Post dx (months) – Enter the number of months from the time of initial brain
tumor diagnosis to surgical resection. For studies with more than one BTS, enter the
average TPO. If only descriptive information is available enter the descriptive
information using the code “O-other” (e.g., O- ‘newly diagnosed tumor’).
Z. Surgical Tx Timing in relation to other medical treatment: Briefly describe the
timing of the awake craniotomy in relation to more general tumor-related medical
treatments (Examples: Chemotherapy began 1 week following surgical resection.).
AA. Living Situation – Summarize living situation using these codes:
A=Lives alone
F = Lives with family/friends
M = Lives in a medical/assisted living facility and receives professional care
O = Other - specify
For studies with more than one BTS participant, enter the number of participants in each
category (e.g., A-3; F-5).
AB. Hand – Indicate handedness using these codes:
R=Right-handed
L= Left-handed
A=Ambidextrous
O = Other- specify
For group studies, enter the number of participants in each category (e.g., R-3; L-2). If
numeric data is not available enter any available descriptive data (e.g., R&L participants
were included).
AC. Ethnicity/Language Spoken – Use the following codes to indicate ethnicity:
AmI=American Indian or Alaska Native
A=Asian
BAAm=Black or African American
NH=Native Hawaiian or another Pacific Islander
W=White
Enter the number of participants in each category (e.g., W-2; BAAm-1). If numeric data
is not available enter any available descriptive data (e.g., White, BAAm, and Asian
participants; or Mixed ethnicity sample)
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If a language other than English is spoken by the participant(s), include any data on the
language spoken by the participant(s) (e.g., O-3 Italian speaking, 3 French speaking or
A-6-3 Mandarin, 3 Cantonese).
AD. Location of Tumor: Laterality – Use the following codes:
R = right hemisphere
L = left hemisphere
B = bilateral
Enter the number of BTS participants in each category (e.g., L-2; B-2). If numeric data is
not available enter any available descriptive data (e.g., Tumors were located in L, R,
and/or bilateral structures)
AE. Location of Tumor: Anatomic areas – List the anatomic structures affected by the
tumor. Note that the location of the tumor is sometimes indicated by the name of the
tumor (e.g., ‘medullosblastoma’ indicates that the tumor includes tissue in the
cerebellum. If you are unsure if the name provides information about tumor location, use
the reference search engines listed at the top of pg. 3 of this document. Use the following
codes to denote tumor location:
AF = Arcuate Fasciculus
BG = basal ganglia
BS = brainstem
Ce = cerebellar
FL = frontal lobe
HPC = hippocampus
Hypo = hypothalamus
I = insula
L = limbic
Me = medulla
Mi = midbrain
MLF = middle/medial longitudinal fasciculus
OL = occipital lobe
Po = pons
PL = parietal lobe
Th = thalamus
TL = temporal lobe
UF = uncinate fasciculus
O-specify = other (specify)
If more than one structure is identified (which will often be the case), list all structures
(e.g., FL, I, PL, TL). If more specific information is provided (in addition to the basic
anatomic structure) follow the code with a dash and include the area affected (e.g., FL–
Broca’s area, PL-post central & supramarginal gyrus). For small n studies (≤ 5 BTS
participants) list the regions for individual participants (e.g., P1: FL-Brocas area; P2-PLangular gyrus). For larger group studies > 5 BTS participants) enter the tumor locations
included in the study as a single list.
AF. Tumor type - Identify the type of tumor (e.g., astrocytoma). For studies with more
than one BTS, enter the number of participants with each tumor type (e.g., astrocytoma3; glioma-2). If numeric data is not available enter any available descriptive data (e.g.,
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Participants had various types of tumors including: astrocytomas, gliomas, and
meningiomas). See appendix B for a list of common tumor types.
AG. Tumor grade – Use the following (WHO/American Brain Tumor Society codes to
enter the tumor grade as specified by the study author(s):
I = Grade 1
II = Grade 2
III = Grade 3
IV = Grade 4
O = Other –specify (e.g., O-tumors varied with respect to complexity)
For studies with more than one BTS participant, enter the number of participants with
each tumor grade (e.g., I-3; II-1). If numeric data is not available enter any available
descriptive data (e.g., varied, including: Grades II-IV). If tumor grade is not explicitly
stated, simply code as missing information (i.e., enter “.”)
AH. Tumor Diagnostic Criteria – Enter the criteria used to diagnose the brain tumor
using the following codes:
PE = Physical examination of brain and spinal cord function (reflexes, muscle
strength, vision, coordination, balance, alertness) by a medical professional–specify
professional (e.g., PE– Physician or PE – neurologist or PE– not specified). If
multiple medical professionals were involved in the diagnosis, list all professionals.
I = Imaging – specify test (e.g., I-MRI; I-CT, etc.). If multiple tests were used, list all
tests.
B = Biopsy – Specify type (e.g., B - Stereostatic or B- Open/craniotomy).
If more than one criterion was used, list all criteria that were used (e.g. PE-not specified,
I-PET, B-Open).
AI. Comorbidities: Speech/Swallowing– List any comorbidities associated with
speech/swallowing using the following codes:
A=Apraxia
Dysarth=Dysarthria
Speech= general speech motor impairment (type not specified)
Dysphag=swallowing impairment
O=Other (specify)
If more than one comorbidity is identified, list all (e.g., A, Dysarth, Dysphag). If
specified, indicate whether co-morbidity is associated with tumor (t) or unrelated (u) or
not specified (NR) (e.g., A-t). For studies with more than one BTS, enter the number of
participants with each co-morbidity (e.g., A-2, Dysarth-2). If numeric data is not
available enter any available descriptive data (e.g., O-varied, including: Speech &
Dysphag).
AJ. Comorbidities: Other - List other comorbidities using the codes:
C = Cognitive-specify
Psy = Psychiatric-specify
S = Sensory-specify
M = Motor-specify
Med = medical-specify
For studies with more than one BTS, enter the number of participants with each comorbidity (e.g., C-executive function-2; Psy-depression-2). If numeric data is not
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available enter any available descriptive data (e.g., O-varied, including: depression,
headache).
AK. Preoperative Neuroimaging - List any additional neuroimaging data that was
provided to support treatment planning using the following codes:
CT = cat scan
MRI/fMRI = magnetic resonance imaging/ functional magnetic resonance
imaging
PET = positron emission topography
EEG= electrocorticography
F= fluoroscopy

TMS/nTMS= transcranial magnetic stimulation/navigated transcranial magnetic
stimulation
Other-specify
For studies with more than one BTS, enter the number of participants for which each
neuroimaging technique was used (e.g., CT-2, MRI-8).
VII. Pre-operative Language Assessment (Columns AL-AT)
→METHODS/RESULTS
AL. Name of Pre-operative Language Assessment(s) -List any pre-operative language
assessments used (e.g., BNT, DO80, etc.). If specific data is not available list/enter any
available descriptive data (e.g., speech and language tasks such as naming or battery
used to assess patient’s cognitive and communicative abilities).
AM. Timing of Pre-operative Language Assessments(s) in Relation to Awake
Craniotomy- Describe the timing of pre-operative language assessments, as given by the
author (e.g., All pre-operative language assessments were completed 1 month to 1 week
before surgery; or Language baselines were collected the day prior to surgery).
AN. Standardization – Indicate whether at least one of the pre-operative language
assessments was standardized (i.e., replicable) using the following codes:
Y = Yes
N= No
If yes, also re-enter the abbreviated name of the assessment/task (e.g., Y- WAB-2) or the
general description as given by author (e.g., experimental dynamic assessment task),
followed by a subcode for intended population of the assessment. Use the following
codes (e.g., Y-WAB-2- G):
BT = Standardized specifically for brain tumor populations
G= Test for more general populations (e.g., general aphasia test or general
cognition test)
AO. Pre-operative Training/Trials of Intraoperative Items- Indicate whether the
intraoperative language assessment items were trained or trialed (e.g., excluding incorrect
items from test stimuli) prior to the awake craniotomy using the following codes:
Y= Yes
N= No
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If Yes (Y), also indicate whether the pre-operative training/trials did (Y) or did not (N)
impact the subsequent intraoperative language assessment protocol (e.g., Y-N, or Y-Y-five
images were removed from the items used intraoperatively).
AP. Language Domains Assessed Pre-Operatively – List all the language domains
assessed during the pre-operative language assessments using the following codes:
N= Naming (confrontational or convergent naming, noun or verb)
AS = Automatic speech (e.g., counting, days of the week)
R = Reading
W = Writing
SS = Spontaneous Speech
AC = Auditory Comprehension
SynG = Syntax/Grammar
P = Phonology
Sem= Semantics (e.g., sorting, picture-word matching)
Rep = Repetitions
F= Timed fluency tasks (e.g., generative naming and/or speech efficiency)
BL = Bilingual speakers (e.g., naming in secondary language/code switching)
Cal = Calculation
VM = Verbal memory
VR = Verbal reasoning/judgement
O = other -specify
AQ. Description of Pre-operative Language Assessments/Tasks – Include the authors
description of the pre-operative language assessment tasks. (e.g., “The test battery
included Swedish standard tests to detect aphasia,
and instruments for detecting more subtle language disorders. The latter included tests of
lexical retrieval
(naming and word fluency) and a test (BeSS) of high-level language functions”
(Antonsson et al., 2017)).
Depending on the level of description included by the authors, this may be the same as
column AM.
AR. Presentation Modality- List all of the methods used to present pre-operative
language assessment stimuli using the following codes:
C= laptop computer/computer monitor
ED= another electronic device (e.g., iPad)
Flash= physical flash cards
B= binder or standardized assessment stimuli booklet
VR= virtual reality
O=Other-specify
If further information is given, use a secondary coding (e.g., L- powerpoint).
AS. Duration of Pre-operative Language Assessment(s) – Enter the amount of time used
for all pre-operative language assessments, in minutes. If numerical is not available or
only partially calculable (from a standardized manual), enter the estimated data and any
descriptive data (e.g., WAB-2 approximately 45, plus additional tasks).
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AT. Existing Language Impairment- Pre-operative- Enter the level of severity (as
specified by the study authors) during the pre-operative period based off the pre-operative
language assessments or report the assessment score(s). Use the following codes:
N = Normal Function
Mi = Mildly Impaired
Mo = Moderately Impaired
S = Severely Impaired
O = Other-specify (e.g., ‘O-borderline normal’)
If there is information on which language domains are impaired, indicate them with a
subcoding (see AQ): (e.g., Mi-N).

If no terms are used to describe the severity level of the aphasia, but scores are provided
for a standardized
aphasia test (e.g., WAB-R), enter the name of the test followed by a dash and then the
summary score (e.g.,
‘WAB-R AQ-92’).

For studies with more than one BTS participant, enter the number of participants with
each level of aphasia severity (e.g., ‘Mi-2, S-2’). If numeric data is not available, enter
any available descriptive data (e.g., ‘O-varied, including Mi & Mo’ or ‘O-WAB-R AQ:
47-92’)
VIII. Intraoperative Mapping and Resection: Medical/Technical (columns AU-BB)
→ METHODS/RESULTS
This section covers specifics related to the technical and medical aspects of
intraoperative mapping and resection (as opposed to aspects of the language
assessment/mapping). If no information is provided about the procedure, code as missing
data (i.e., enter “.”)
AU. Inclusion/Exclusion Criteria of Awake Craniotomy Participant Selection- Enter
any inclusion/exclusion criteria considered when evaluating patient eligibility for awake
craniotomy procedure, as the author(s) described them (e.g., “Patients with major
neurological deficits that preclude testing of function (pronounced aphasia or motor),
poor neuropsychological scores (Mini-Mental State Examination, Aphasia Quotient
Score for language function), significant deficits in concentration and sustained
attention, patients suffering with severe anxiety or depression, claustrophobia,
disinhibition, apathy and disorganized behavior were not candidates for awake
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craniotomy” (Chowdury et al. 2018)). If there is no information for patient eligibility,
enter ‘.’.
AV. Prior Surgeries – Indicate whether any of the BTS participants previously
underwent surgery using the following codes:
Y = Yes
N = No
If yes, specify the number of BTS participants that underwent surgical treatment prior to
the report (e.g., Y-4).
AW. Ratio Underwent Awake Craniotomy- Enter the number of BTS participants that
underwent awake craniotomy treatment in ratio to the total number of BTS participants in
the study (e.g., 11/20).
AX. Type of Intraoperative Imaging- Indicate the mapping technique used with the
following codes. List all intraoperative imaging techniques used in the study.
DES= direct electrocortical stimulation/direct cortical stimulation, etc.
iMRI= intraoperative MRI
eCoG= electrocorticography
F= fluoroscopy
O= other (specify)

AY. Imaging Specifications- Give a brief description of the imaging specifications as
described by the author. If more than one intraoperative imaging technique was used,
enter the intraoperative imaging type code followed by the description (e.g., ‘DES-bipolar
stimulator with tips spaced 5 mm apart, biphasic current with pulse frequency 60 Hz, stimulation
4 sec’).

AZ. Identification of Language Sites- Give a brief description of how language (positive
and/or negative) sites were defined intraoperatively by study authors (e.g., “A site was
considered eloquent (language positive) if disturbances were observed in more than two
trials”).
BA. Extent of Resection (EOR)- Enter the extent of resection using the following codes,
followed by the number of patients that received the level of resection (e.g., GT-22, ST30, SpT-2):
GT= Gross Total (complete removal of all tumors visible in MRI)
ST= Subtotal (some tumorous tissue is left)
SpT= Supratotal (complete removal of all tumorous tissue visible in MRI and
some additional unaffected brain tissue beyond the tumor border)
If this data is unavailable, enter any description given by the author (e.g., mean % of
resection) OR calculate the mean extent of resection if possible.
IX. Intraoperative Language Ax for BTS (columns BB-BQ) →
METHODS/RESULTS
This section covers specifics related to the intraoperative language assessment (as
opposed to pre- or post-surgical assessments/language therapies). If no information is
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provided about the language and/or communication assessment, code as missing data
(i.e., enter “.”)
If the description or information on the assessment task comes from a secondary (citated)
source, enter “.” in the column followed by a “-“or “*” and the description from the
secondary source. Be sure to include the reference.
BB. Presentation Modality- List all of the methods used to present intraoperative
assessment stimuli using the following codes:
L= laptop computer
ED= another electronic device (e.g., iPad)
Flash= physical flash cards
B= binder or standardized assessment stimuli booklet
VR= virtual reality
O= Other- specify
If further information is given, use a secondary coding (e.g., L- powerpoint).
BC. Total Duration of Assessment (minutes)- Enter the total time the patient was awake
for intraoperative language mapping assessment, in minutes (e.g., 90). For studies with
more than one BTS participants, enter the average duration of assessment (e.g., mean 100
or range 45-90).
BD. Administrator of Intraoperative Ax – Specify who administered the intraoperative
assessment using the following codes:
SLP = Speech-language pathologist/therapist
NP = Neuropsychologist
O = Other (Specify)
Before completing this section (BE-BP), review IEF Items 7 and 8
Summarize information for at least 3 primary tasks/measures (M). The following should
be directly related to and further detail the tasks identified in inclusion/exclusion
screening (see IEF, items 7 and 8)
BE (M1), BI (M2), & BM (M3). Intraoperative Language Assessment (M) (subtest or
task): Name–Enter the subtest/task name or a description of the task, as provided by the
author (e.g., modified BNT or nonverbal semantic associations task).
BF (M1), BJ(M2), & BN (M3). Task Standardization- Enter whether the measure (task)
follows a standardized (formal) procedure using the following codes:
Y = Yes
N= No
If yes, follow up with two subcodings. Use the following codes:
First:
BT = Standardized specifically for brain tumor populations
G= Test for more general populations.
Second:
IO = Standardized specifically for use during intraoperative context
Gen= Standardized for general or other (not intraopearative context)
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BG (M1), BK (M2), & BO (M3) Language Domain Assessed- Enter the language
domain(s) assessed by the intraoperative language assessment task using the following
codes:
N= Naming (confrontational or convergent naming, noun or verb)
AS = Automatic speech (e.g., counting, days of the week)
R = Reading
W = Writing
SS = Spontaneous Speech
AC = Auditory Comprehension
SynG = Syntax/Grammar
P = Phonology
Sem= Semantics (e.g., sorting, picture-word matching)
Rep = Repetitions
F= Timed fluency tasks (e.g., generative naming and/or speech efficiency)
BL = Bilingual speakers (e.g., naming in secondary language/code switching)
Cal = Calculation
VM = Verbal memory
VR = Verbal reasoning/judgement
O = other -specify
BH (M1), BL (M2), & BP (M3) Description of Task- Give a brief description of the task
as given by the author (e.g., “Patients are given a black-and-white drawing or a video of
an action, and they are asked to answer with a verb in the infinitive (e.g., ‘to jump’) or in
the progressive form (‘jumping’” (Bogka et al., 2003); or Patients counted backward from
20).
BQ. Additional Tasks- If more than three intraoperative language assessments were
completed, enter the domain and corresponding assessment/task name here (e.g., SSconversation between tasks or O-Line Bisection Task).
X. Post-Operative Language Outcomes (columns BR-CF) → RESULTS
This section covers specifics related to any language outcomes following surgical
treatment. If no information is provided about the language and/or communication
intervention, code as missing data (“.”).
Post-Operative Language Assessment (columns BR-BY)
BR. Timing of Follow-up(s) – Enter the number of follow-ups and timing in relation to
awake craniotomy, in weeks (W) or months (M). For example, ‘3-1W, 3M, 6M.’
BS. Name of Post-operative Language Assessment(s) -List all of the post-operative
language assessment(s) used (e.g., BNT, DO80, experimental dynamic assessment task,
etc.) to assess language outcomes.
BT. Standardization – Enter the formal standardized test that was used to assess postoperative language outcome and diagnosis of potential aphasia. (e.g., WAB-R, BDAE),
followed by a subcoding for intended population. Use the following codes (e.g., WAB-2G)
BT = Standardized specifically for brain tumor populations
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G= Test for more general populations.
BU. Language Domains Assessed Post-Operatively – List all the language domains
assessed during the pre-operative language assessments using the following codes:
N= Naming (confrontational or convergent naming, noun or verb)
AS = Automatic speech (e.g., counting, days of the week)
R = Reading
W = Writing
SS = Spontaneous Speech
AC = Auditory Comprehension
SynG = Syntax/Grammar
P = Phonology
Sem= Semantics (e.g., sorting, picture-word matching)
Rep = Repetitions
F= Timed fluency tasks (e.g., generative naming and/or speech efficiency)
BL = Bilingual speakers (e.g., naming in secondary language/code switching)
Cal = Calculation
VM = Verbal memory
VR = Verbal reasoning/judgement
O = other -specify
BV. Description of Post-operative Language Assessments/Tasks – Give a brief
description of the task as given by the author (e.g., a more complete version of the BNT
than was administered intraoperatively was used to assess naming or Patients counted
backward from 20).
BW. Presentation Modality- List all of the methods used to present pre-operative
language assessment stimuli using the following codes:
C= laptop computer/computer monitor
ED= another electronic device (e.g., iPad)
Flash= physical flash cards
B= binder or standardized assessment stimuli booklet
VR= virtual reality
O=Other-specify
If further information is given, use a secondary coding (e.g., L- powerpoint).
BX. Duration of Post-operative Language Assessment(s) – Enter the amount of time
used for all post-operative language assessments, in minutes. If numerical is not available
or only partially calculable (from a standardized manual), enter the estimated data and
any descriptive data (e.g., WAB-2 approximately 45, plus additional tasks).
BY. Existing Language Impairment- Post-operative- There are several parts to this
question.
First, Enter the level of severity (as specified by the study authors) during the postoperative period based off the last post-operative language assessments, or report the
assessment score(s). Use the following codes:
N = Normal Function
Mi = Mildly Impaired
Mo = Moderately Impaired
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S = Severely Impaired
O = Other-specify (e.g., ‘O-borderline normal’)

If no terms are used to describe the severity level of the aphasia, but scores are provided
for a standardized
aphasia test (e.g., WAB-R), enter the name of the test followed by a dash and then the
summary score (e.g.,
‘WAB-R AQ-92’). For studies with more than one BTS participant, enter the number of
participants with each level of aphasia severity (e.g., ‘Mi-2, S-2’). If numeric data is not
available, enter any available descriptive data (e.g., ‘O-varied, including: Mi & Mo’ or
‘O-WAB-R AQ: 47-92’)

Second, indicate the trajectory of language outcomes using the following format: participant ID/group-timing(#W/M)- Descriptive/statistically significant (D/SS)Increase/Decrease (I/D)domains (list). E.g., Mi-CRA-1W & 3M-SS-I-N.
BZ. Patient/Caregiver-Reported Language Outcomes – Report any language outcomes
as reported by the patient or caregiver (e.g., ‘caregiver reported word finding
difficulties’).
Post-Operative Language Therapy Treatment (columns CA-CG)
CA. Post-Operative Language Therapy Treatment Name- Enter the name of the
Treatment (e.g., ‘Semantic Feature Analysis’) and/or the treatment approach (e.g., ‘Life
Participation’). If no information is provided other than “language treatment,”enter
‘language treatment.’
CB. Duration of Language Therapy Treatment Sessions- Enter the length of treatment
sessions in minutes (e.g., 50).
CC. Frequency of Language Treatment Sessions– Enter the frequency that treatment
was administered using
the following codes:
D = Daily-specify frequency (e.g., D-x1 to indicate sessions occurred once daily).
W= Weekly-specify frequency (e.g., W-x3 to indicate 3 sessions/week)
M= Monthly-specify frequency (e.g., M-x2 to indicate 2 sessions/month)
A = Annually-specify frequency (e.g., A-x1 to indicate 1 session annually)
L = Limited-specify frequency (e.g., L-2 sessions administered post-surgery)
O = Other-specify frequency (e.g., O-sessions administered at patient request)
CD. Number of Language Therapy Treatment Sessions – Indicate the total number of
treatment sessions that were actually administered. For studies with more than one BTS
participant, enter the average number of treatment sessions.
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CE. Duration of Treatment – indicate in weeks the actual duration of treatment (e.g., 6).
CF. Language Domains Addressed in Post-Operative Language Treatment- List all the
language domains addressed during the post-operative language treatments/therapy
using the following codes:
N= Naming (confrontational or convergent naming, noun or verb)
AS = Automatic speech (e.g., counting, days of the week)
R = Reading
W = Writing
SS = Spontaneous Speech
AC = Auditory Comprehension
SynG = Syntax/Grammar
P = Phonology
Sem= Semantics (e.g., sorting, picture-word matching)
Rep = Repetitions
F= Timed fluency tasks (e.g., generative naming and/or speech efficiency)
BL = Bilingual speakers (e.g., naming in secondary language/code switching)
Cal = Calculation
VM = Verbal memory
VR = Verbal reasoning/judgement
O = other -specify
XI. Quality of Evidence for Study (columns CG-CN) – This section should be
completed based on information provided throughout the publication. If no information is
provided about the language and/or communication assessment, code as missing data (i.e.
enter “.”)
CG. Design Description (By Author)- provide a brief description of the
(language/communication) tx study
design as described by the author (e.g., ‘Case report’ or ‘Clinical recommendations’ or
‘Group study’).
CH. Design Type – Enter your assessment of the design type based on the authors’
description and other related information provided in the abstract and results section of
the document. Use the following codes (Tate et al., 2013; see also ANCDS criteria):
Uncontrolled non-experimental studies (no control group, condition, or phase):
Corr = Correlational study comparing the relation between two variables
Case = Case series – an uncontrolled clinical description of treatment of one or
more persons (data are not averaged across cases), includes B (data collected
during tx phase only), AB (data collected before and during treatment); and
Pre/Post (data collected before and after tx, but not during tx)
UG = Uncontrolled (no control group/condition) descriptive group (data are
averaged across participants) study
Controlled experimental studies (either a repeated control phase in single
participant designs, or a control condition/group in group studies):
SPD = Single participant design (data are not averaged across individuals) – an
experimentally controlled treatment in which i).the individual with
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tumor(s) serves as his/her own control by prospective and intensive study
during multiple (minimum of two) treatment phases (usually A&B); ii).
There is a specific operationally defined behavior targeted for treatment
that is measured repeatedly during all phases; includes classic
withdrawal/reversal e.g. ABA designs and extensions (e.g., ABCBC),
multiple baseline design (MBD) across participants, MBD across
behaviors, MBD across contexts, multiple probe design, alternating
treatments design (ATD), changing criterion design, and other
combinations.
CGD = Controlled (there is a control condition or group) group (data is averaged
across individuals) design. Includes within and between group designs.
RCT = CGD with random assignment of participants to different experimental
conditions/treatments
MA = Meta-Analysis providing a statistical summation of multiple controlled
experimental studies
O = Other-specify
Three quality rating scales should be completed for all publications. First, for all
publications, complete the ASHA Quality Indicators Scale (ASHA QI in column CI),
developed for all study designs. Second, complete the quality rating scale that
corresponds to the specific study design. Specifically, complete the RoBiNT scale
(column CJ) for small n studies (case studies and/or single subject designs, results not
averaged across individuals); OR the PEDro scale (column CK) for group studies (results
averaged across individuals) OR the RQR scale (column CL) for qualitative studies.
Lastly, complete the [NitkoMurrayRohde] scale (column CM) developed for this review.
All worksheets used to compute ratings are listed as separate tabs in the excel file.
CI. ASHA Quality Indicators (ALL studies) – After reading the full publication,
complete the ASHA QI worksheet (Cherney et al., 2008) as it pertains to the
intraopearative language/communication assessment and enter the total ASHA QI score
in this column.
CJ. RoBiNT (Single subject/small n studies only) – After reading the full publication,
complete the RoBINT (Tate et al., 2013) worksheet as it pertains to the intraoperative
language/communication assessment and enter the total RoBiNT score in this column.
CK. PEDro (Group studies only) – After reading the full publication, complete the
PEDro worksheet (Murray et al., 2013) as it pertains to the intraopearative
language/communication assessment and enter the total PEDro score in this column.
CL. RQR (Qualitative studies only) - After reading the full publication, complete the
RQR (Simmons-Mackie et al., 2016) worksheet and enter the total RQR score in this
column.
CM. NitkoMurrayRohde (All studies) – After reading the full publication, complete the
NitkoMurrayRohde worksheet as it pertains to intraoperative language/communication
assessment and enter the final score in this column.
CN. Level of Evidence (AAN) – Classify the design type using the American Academy
of Neurology (AAN) classification codes:
3 = Corr, Case, or UG designs
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2 = SPD or CGD
1 = RCT or MA
XII. Study Conclusions (columns CO-CU) → DISCUSSION
If no information is provided about the language and/or communication assessment, code
as missing data (i.e. enter “.”). Before completing this section, review columns I, K, & M
which summarize study purpose & results (from abstract) and research questions (from
introduction).
CO. Results: Main Study Findings- From the Results section, summarize the primary
study findings corresponding to the research questions listed in columns K and/or M
using the following coding format
(Note: Complete for only 1 finding/RQ for up to3 RQs):
RQ#-specify analysis test- primary finding including # participants-test statisticprobability level
[e.g., RQ1-Barnard’s test- 3/5 participants had more naming errors during DES vs. no
DES condition- (WALD r:4.062, 2.646, 3. 821; nuisance .06, .11, .14)-p <.01]
CP. Descriptive Summary of Main Findings – Based on information provided in the
Discussion section:
a. Provide a single sentence that best summarizes the authors’ main
conclusion for each research question (these should correspond to the
research questions specified in column M). Specify i. the research
question and ii. whether the conclusions apply to all study participants
OR specifically to participants with intraoperative mapping for brain
tumor, and iii. The primary study conclusion. Examples:
RQ1 Ax Validity: Results of this study suggest that the protocol is
valid for intraoperative language mapping in individuals with parietotemporal brain tumor.
RQ2 DV Effectiveness: Furthermore, results for Ax using virtual
reality compared to traditional presentations indicated that virtual
reality assessments are viable for expanding intraoperative assessment
stimulus.
b. Additional information/commentary can be included (use grey font)
following this initial summary sentence. Only the initial sentence will
be counted towards reliability. Example: RQ2 Comparison of 2
Assessments: For automated speech tasks there was no SS difference
between virtual reality or physical cards; Pts who were younger were
less likely to have visual adjustment time in virtual reality
presentation.
CQ. Conclusions: BTS vs other populations – Based on information provided in the
Discussion section, provide a one sentence summary of any conclusions made by the
authors that directly compare outcomes for participants with brain tumor with
participants who have other etiologies (e.g., There was no difference in the performance
of participants on the task regardless of whether surgical treatment was for brain tumor
resection or epileptic seizures).
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CR. Author Recommendations: List any clinical/research recommendations made by the
authors with respect to intraoperative language assessment for BTS. Use the following
codes:
MR = More research needed-specify
MDI = More demographic information needed about participants with BT–specify
MLTI = More language treatment information needed–specify
MMTI = More medical treatment information needed-specify
O = Other–specify
CS. Interesting Discussion Items- There will be no reliability on this column. Enter
anything from the discussion that you found interesting or worth noting. This could
include comments on the discussion, any discrepancies, interesting findings that were not
captured by the RQs, etc. (e.g., differences in activation/DES response between
cortical/subcortical, or other neuroanatomical areas and/or participant populations).
CT. Reviewer Comments/Questions – Enter any general comments/questions that you
have about the publication/coding here. For questions that are specific to information in a
particular column, specify the column.
CU. Questions for Study Authors – Specify any questions for clarification that you
would like to as the study authors.
XII. Ancestral Search (column CV) → REFERENCE LIST
CV. # References – After reading the study references and completing the References
worksheet, enter the total number of references that you think have a strong probability of
addressing intraoperative speech/language assessment for adult brain tumor survivors.
List the references of interest in the “Ancestral Search” tab on the data extraction
spreadsheet.
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